Development of a novel platform for the identification of synthetic lethal genes in a Kras and Keap1-mutant mouse model of lung adenocarcinoma
Understanding G alpha q/11 localization and trafficking in uveal melanoma
2017
(PQ #4) Single cell barcoding for studies of study clonal evolution in glioblastoma
(PQ1) Cellular senescence as an initiating event in malignant transformation
(PQ1) Identifying and targeting human glioblastoma migrating in the peritumoral niche
(PQ1) Molecular circuit of multi-ciliogenesis regulates choroid plexus differentiation and tumor development
(PQ1) Progenitor cell malfunction, mutations and changes in microenvironment: A dynamic risk spectrum for cancer evolution
(PQ5) Effect of HIV infection on viral and host gene expression and antitumor immunity in Kaposi Sarcoma in Africa
(PQ5) Exploring the Biological Distinctions between HIV-related and Endemic Pediatric Kaposi Sarcoma in a Kaposi Sarcoma-Associated Herpesvirus-Endemic Region of Africa
(PQ7) A multi-fluorescent intravital microscopy approach to study osteosarcoma
(PQ7)Multi-scale Analysis of Tumor Microenvironment Heterogeneity
(PQ8) Genetically faithful murine models for studying disease progression in chronic lymphocytic leukemia
(PQ9) Directed and unbiased studies of synaptic injuries as sequelae of radiotherapy: mapping, sex-dependence, and reversal
(PQ9)A redox-mediated mechanism of chemotherapy-induced cognitive impairment
2017 Cholangiocarcinoma Foundation Annual Conference
2D MR Correlational Spectroscopy Platform for Molecular and Genetic Characterizations of Glioma
4-Channel Multimodal Ultrathin-Flexible SFE for cancer diagnosis and therapy
5th International RASopathies Symposium
A clones genomic stability as biomarker of its DNA-damage resilience
A First-in-Human Pilot Study of 18F-MFBG Imaging for Evaluation of Neuroblastoma
A highly specific NIRF/PET probe for the detection of cancer and metastases
A Mobile-Support Program to Facilitate Nutritional Caregiving in Head and Neck Cancer
A network-based approach for personalized treatment of Multiple Myeloma
A new class of CSF-1R radioligands for monitoring glioblastoma progression and therapy
A New Ovarian Cancer Mouse Model Based on Nanoparticle Gene Delivery
A Novel Agent for Ovarian Cancer
A novel approach for the selective inhibition of HIF-2a in kidney cancer
A Novel Molecular Imaging Agent for Surgical Resection of Invasive Brain Tumors
A Novel Mouse Model for Uterine Leiomyoma
A novel point of care test for oral and oropharyngeal cancer risk
A Novel Targeted Nanomedicine Delivering MicroRNA-30-5p Replacement Therapy for Multi-drug Resistant Cancer Treatment
A novel VLP vaccine to prevent EBV infection and EBV – associated malignancies
A Phase 1 Study of M032, a Genetically Engineered HSV-1 Expressing IL-12, in Patients with Recurrent/Progressive Glioblastoma Multiforme, Anaplastic Astrocytoma, or Gliosarcoma.
A Phase I Clinical Trial: Binary Therapy with DM-CHOC-PEN and WBRT in Adults with Cancer Involving the CNS
A phase IIA trial for the safety and tolerability of CD24Fc in prophylaxis of graft vs host disease.
A Potent and Specific Approach to Targeting B-Cell Lymphoma: Disrupting Malignant Protein-Protein Interactions Using CD19-Targeted Stapled Peptide Amphiphile Nanoparticles
A role for notch in self renewal in embryonal rhabdomyosarcoma
A Scalable Blood-based Pancreatic Cancer Test for High-Risk Screening
A Systems Biology Approach to Mechanisms of PARP Inhibitor Resistance in Ovarian Cancer
A Unique Class of Reductively Activated Oncology Drugs
ABT-199 based therapies to treat neuroblastoma
AML-MutationCounter, a tool to detect residual and recurrent leukemia
An 18F PET/NIRF Smart Probe for Identifying, Grading, and Visualizing Astrocytic Gliomas
An Automated, Optical Imaging Platform for Early Detection of Oral Neoplasia
An Imaging Technology for Intra-Operative Surgical margin assessment in oral and Head and Neck Cancers (OSCC)
An in vivo model for CCNE1 amplified tumorigenesis
Analysis of the novel phenomenon of antibody-mediated fratricide in Acute Myeloid Leukemia
Annual anal sampling using DNA screening to identify men who have sex with men at increased risk for anal cancer
Anticancer peptide therapeutics
Anti-CD38 targeted alpha emitter radioimmunotherapy to eliminate multiple myeloma
Antivascular ultrasound therapy of primary liver neoplasia
Area A: Development of genetically tractable, driver gene-syngeneic brain tumor models for pre-clinical adoptive TCR-T therapy
Area A: In-Depth Proteome Mapping of the Tumor Microenvironment with Single-Cell Resolution
Area B: Precise DCE-MRI Assessment of Brain Tumors
Assessment of Chemotherapy-Induced Peripheral Neuropathy Susceptibility Using Patient-derived iPSC Technology
Asymmetric cell division drives therapeutic resistance and self-renewal in glioblastoma
At the nexus of redox and signaling pathways: regulation of NAD+ kinase
Augmented Neurosurgical Navigation Software Using Resting State MRI
Automation of MicroC3 as a CDx for myeloma therapies
BET protein antagonist-based targeted therapy of Mantle Cell Lymphoma
Bioinformatic Analysis of Next Generation Sequencing Data from Cancer Cells
Biologic for the Treatment of High Risk B Cell Acute Lymphoblastic Leukemia
Blood biopsy test for pan-cancer mutations with error-checking probes
Brain Cancer Radio-Pathomics for Predicting Heterogeneous Cytology
Brain Tumor Epidemiology in the Era of Precision Medicine
Breaking the paradigm: RhoA as a tumor suppressor in cancer
Breakthrough sub-cellular 3D chemical composition research platform for live cells, based on the new invention of nanoscale – confocal photothermal IR micro-spectroscopy (n-CPIR)
Building protected data sharing networks to advance cancer risk assessment and treatment
Cadherin Regulation of Glioma Invasion: A Biophysical Perspective
Cancer Cell Mechanical Profiling Analysis
Cancer Epigenetics: A novel PRC2 Dysregulation Mechanism in Multiple Myeloma
Candidate Gene Resequencing of Germline Multiple Myeloma
Canine Immuno Neurotherapeutics
CD25-mediated feedback control of BCR-signaling and its oncogenic mimics
CD40L-Modified Chimeric Antigen Receptor (CAR) T Cells
Cell Cycle Blockade and Therapeutic Sensitization
Cell survival by anastasis, a novel therapeutic target in cancer
Cellular and molecular basis of microRNA-29a Induced Acute Myeloid Leukemia
CEST MRI assessment of tumor vascular permeability using non-labeled dextrans
Characterization of CD99 as a Therapeutic Target in the Myelodysplastic Syndromes and Acute Myeloid Leukemia
CHARACTERIZATION OF SEXUAL DIMORPHISM IN GLIOMA METABOLISM
Characterizing TP53 and PPM1D mutations as resistance drivers to radiation therapy in Diffuse Intrinsic Pontine Gliomas
Chemical Inhibitors of 15-prostaglandin dehydrogenase Potentiate Hematopoietic Stem Cell Transplantation
Chemical Modulation of Chromatin Signaling in Lymphoid Malignancies
Chemoprevention of lung cancer with mitochondria-targeted honokiol
Chemotherapy-induced MDSCs and antitumor immunity
Clinical Development of JS-K for the Treatment of Cancer
Clinical evaluation of the novel, uni-directional, Pd-103 CivaSheet for Pancreatic Cancers
Clinical Pregnancy Outcomes in Adolescent and Young Adult Female Cancer Survivors
CMV Infection and NK-Cell Therapy for Multiple Myeloma
Co-Evolution of the CD8+ T Cell Repertoire and AML In the Setting of Immunotherapy
Cohesin Mutations in Acute Myelogenous Leukemia
Combination of ceramide and immunotherapy in treatment of hepatocellular cancer
Commercializing Praedicare Dx TM platform for guiding cancer treatments
Common genetically altered pathways as targets for therapy in pancreatic cancer
Compensatory mechanisms that promote homologous recombination in BRCA1 mutant cancers
COMPREHENSIVE INFORMATIC ANALYSES OF AML GENOMES AND EPIGENOMES
Context-Specific Functional Annotation of EGFR Mutations in Glioblastoma
CONTRAST-ENHANCED ULTRASOUND EVALUATION OF FOCAL LIVER LESIONS IN PATIENTS WITH CIRRHOSIS OR OTHER RISK FACTORS FOR DEVELOPING HCC
Contribution of Osteocytes to the Musculoskeletal Effects of Multiple Myeloma
Coordinating center for the NCI small cell lung cancer research consortium
Copy Number Alterations in Low Mutation Cancer
Core Laboratory for Advanced PET and MRI image analysis
Creation of in vivo active chemical probes for CAMKK2 to treat cancer
Deciphering How Esco2 Loss Acts as a Penetrance Modifier
Deciphering the role of Lin28b in pancreatic cancer to guide therapeutic discovery
Defining a mechanism of LRP1B tumor suppression in glioblastoma
Defining and targeting mechanisms of pancreas cancer pathogenesis
Defining diverse roles of p53 in pancreatic cancer
Defining neoantigen immunodominance for antigen selection and biomarker discovery in human pancreatic cancer immunotherapy
Defining Novel Genetic Dependencies in Spliceosome Mutant Leukemia
Defining the barriers to immune surveillance in solid tumors
Defining the Cellular Oncogenome of Kaposi Sarcoma
Defining the non-myogenic origins of pediatric rhabdomyosarcoma
DEFINING THE ROLE OF DOT1L IN DNMT3A-MUTANT LEUKEMIA
Defining the Transcriptional Regulation and Genomic Organization of FAIM3 and PIGR, Human Ig Receptors Involved in Immunity, Auto-Immune Disease, and Lymphoma
Detection of microsatellite instability biomarkers for therapeutic clinical trial eligibility
Determining the Epigenetic Mechanisms Driving Tissue Factor (F3) Upregulation and its Role in Metastatic Osteosarcoma
Determining the Influence Genomic Instability During Embryogenesis has on Tumor Penetrance
Determining the role of DNMT-interacting RNAs in myeloid disorders
Developing ASCL1 and NeuroD1 lineage oncogene targeted therapy for small cell lung cancer
Developing differentiation therapy for the treatment of patients with acute myeloid leukemia
Developing Therapeutic Strategies for Histone H3.3 Mutant Tumors via Rational Targeting of Specific DNA Repair Pathways
Development and application of asymmetric-flow field-flow (AF4) technology in fractionation and characterization of exosome subpopulations and novel nanoveiscles in pancreatic cancer model
Development of a companion diagnostic to predict response to cetuximab in patients with head and neck squamous cell carcinoma
Development of a Four-Class, Molecular Subtyping Diagnostic for HPV-negative Head and Neck Cancer
Development of a molecular diagnostic and prognostic signature for meningioma
Development of a novel Virus-Like Particle vaccine-based cancer immunotherapy targeting PD-L1.
Development of a protein drug for pancreatic cancer treatment
Development of Cell-based Functional Tests for Rare Germline ATM Gene Variants in Hereditary Ovarian Cancer Families
Development of Mantle Cell Lymphoma Proliferation Signature Assay
Development of microfluidic blood-brain tumor barrier model to screen chemotherapeutic strategies for breast cancer brain metastases
Development of mosaic mouse models of HCC for genetic interspecies inference
Development of novel gallium-68 bisphosphonate for imaging bone metastases in prostate cancer
Development of Novel Targeted Chemotherapeutics for the Treatment ofMalignant Pleural Mesothelioma
Development of PEGylated MTI-101 for the treatment of relapsed Myeloma
Development of PET imaging biomarkers to predict enhanced glioblastoma radiotherapy by a novel H-NOX oxygen carrier
Development of Risk and Early Detection Biomarker for Small Cell Lung Cancer
Development of selective Pin1 inhibitors to target a common oncogenic mechanism
Development of SHP2 inhibitors for targeted anti-cancer therapy
Development of whole-brain in vivo 2HG imaging for precision medicine in mutant IDH glioma
Development, Characterization & Commercialization of a Viably Frozen, Patient-Inclusive Hepatocellular Carcinoma Tumor Bank
Dexrazoxane and Prevention of Anthracycline-Related Cardiomyopathy
Digital PCR quantification of BCR-ABL for CML diagnosis and monitoring in a LMICs setting
Discovering mechanisms of neuroblastoma tumorigenesis to improve patient outcomes
Discovery of New Differentiation Agents for Neuroblastoma Therapy
Discovery of Novel Therapeutics for Glioblastoma
Discovery of Synthetic Lethal Targets for Recurrent Epigenetic Mutations in Acute Myeloid Leukemia
Disrupting the immune and drug-privileged microenvironment in pancreas cancer
Dissecting the molecular and functional role of ILK in driving metastatic colonization and progression in Ewing sarcoma
Dissecting the Pathogenesis of Ewing Sarcoma with Integrative Genomics
Dissecting the role of the immune system in the radiation response of Kras-mutant tumors
DNA adductomics of the urinary system
Dysregulation of Glutamine Metabolism in the Pathogenesis of Multiple Myeloma
Early assessment of radiation response in brain tumors using quantitative temporal diffusion spectroscopy
Early Detection of Ovarian Cancer Using Uterine Lavage and Duplex Sequencing
Early prediction of colorectal liver metastases treatment response with ultrasound microvessel imaging
Effects of Common Polymorphisms in Immune Sensors in Tumor Immunosurveillance
Elucidating the mechanism of anti-GSK3 adjuvant therapy for Myc-driven lymphomas
Elucidating the role of cell-specific Wnts in hepatocellular carcinoma
Elucidating the Role of Fasting in GI Radioprotection: Applications in Pre-Clinical Pancreatic Cancer Model
Elucidating the role of the CXCL13/CXCR5 signaling axis in Angioimmunoblastic T-Cell Lymphoma (AITL)
Elucidation of Human Natural Killer Cell Development
Endoscopic Flexible Pancreatic Tumor Ablation System with Reduced Force Effector and Specialized Ablation Zone
Engineered precancerous cells and tissues for discovery of lung cancer drivers
Engineering chimeric antigen receptors with VLR-mediated cancer recognition in CD5 edited gamma delta T cells
Engineering Precision Medicine to Enhance Graft-Versus-Lymphoma Effect
Enhancer RNA-mediated Tumor Suppressor Gene Expression in Normal and Malignant Hematopoiesis
Enhancing anti-EGFR Therapeutic Efficacy in Inflammatory Breast Cancer
Enhancing Chemoradiation Efficacy through Unbiased Drug Discovery Approaches
Enhancing natural killer immunotherapy with first-in-dog trials of inhaled recombinant IL-15 and super-agonist IL-15 in naturally occurring canine cancers
Enhancing the efficacy of immunotherapy in DLBCL using rational combination approaches
Enhancing viral oncolysis with vasculostatin gene delivery
Epigenetic and microenvironmental regulation of dormant disseminated cancer
Epigenetic regulation of cellular plasticity and cancer cell fate
Epigenetic Regulation of Lipid Metabolism in Glioma Stem Cells
Epigenetic regulation of metabolic rerpogramming in pancreatic cancer
Epigenetic therapy for pancreatic cancer
Establishing in vitro carcinoma models of the Alternative Lengthening of Telomeres pathway to elucidate molecular mechanisms and identify therapeutic vulnerabilities
Establishing the validity of brain tumor perfusion imaging
Estimating and communicating spatial certainty when childhood cancers co-cluster
Evaluation of metastatic brain tumor heterogeneity and physiological response to immunotherapy using advanced MRI
Ex vivo culture platform validation for preservation of patient derived multiple myeloma cells
Examination of ceramide signaling in the crosstalk between pancreatic cancer cells and the tumor microenvironment
Examining the Heterogeneity of Fibroblasts in the Pancreatic Microenvironment
Exosomes in tumor cell-mesenchymal stromal cell interaction
Experimental Therapeutics by targeting Spleen Tyrosine Kinase
Exploiting Mutant IDH1/2-induced Homologous Recombination Defects in Cancer
Exploiting vulnerabilities in GIST using novel combination therapies
Exploiting WEE1/p53 synthetic lethality as a novel therapy in head and neck cancer
Exploration of ZHX2 as a novel substrate of pVHL and an oncogenic driver of renal cancer
Exploring factors related to racial disparities in ovarian cancer incidence and survival: the OCWAA consortium
Exploring the regulation and function of gap junction-mediated signaling in glioblastoma multiforme
Exploring the therapeutic potential and pathogenic contribution of MTAP deletion in Glioblastoma
Extracellular Vesicles in Small Cell Lung Cancer Early Detection
Facile screening for esophageal cancer in LMICs
FANCM in repair of stalled replication forks
Fasting Protects Small Intestinal Stem Cells from Lethal DNA Damage: Mechanistic Insight and Preclinical Translation
Feasibility of predicting AML response to induction chemotherapy
FemKube, the human female reproductive tract-on-a-chip, as a platform for studying high grade serous ovarian cancer and developing novel cancer chemotherapeutics
Field-deployable platform for prognostic hepatic cancer screening in low-resource settings
First in human study with 18F-avb6-targeting peptide
First-in-class TREM-1 inhibitors in combination therapy for pancreatic cancer
FOLFOX-induced kinome reprogramming in pancreatic cancer tumor xenografts
Functional dissection of oncogenic enhancers
Functional Effects of Ovarian Cancer Risk Variants
Functional Genomic Discovery of Pathway Targeted and Immune Modulatory Therapeutic Combinations in Hematologic Malignancies
Functional interrogation of epigenetic vulnerabilities in KRAS-mutant pancreatic cancer
Functions of human RAD51 and its paralogs during DNA interstrand crosslink repair
GABPB1L-mediated activation of the mutant TERT promoter as a therapeutic target in glioblastoma
Generating rapid antitumor immunity with lymphocyte-reprogramming nanocarriers
Genetic Predictors of Early Clinical Failure in Diffuse Large B Cell Lymphoma
Glycine metabolism in cancer
Grail-targeting breaks the immune tolerance to melanoma
GRIM19 for head and neck cancer therapy
Harms of Hepatocellular Carcinoma Screening in Patients with Cirrhosis
Hepatobiliary Cancers: Pathobiology and Translational Advances
Identification of Essential Areas of the Brain in Pre-Operative Brain Tumor Patients Using BOLD fMRI and Independent Physiological Parameters
Identification of microRNA variants associated with acute lymphoblastic leukemia
Identifying and targeting oncogenic Myc enhancer control in pediatric tumors
Identifying Genetic Drivers of the Immunosuppressive Tumor Microenvironment in Lung Cancer
Identifying novel effectors of oncogenic Kras in pancreatic cells via proximity labelling
Identifying the Drivers and Targeting Chemo Resistance in Ovarian Cancer
Image Guided Delivery and Evaluation of Low? Density Lipoprotein-Docosahexaenoic acid Nanoparticles for the Management of Hepatocellular Carcinoma
Image-guided, sonoporation-enhanced immunotherapy for pancreatic cancer treatment
imaging Radiation-Associated Dysphagia (iRAD)
Immune epigenetic biomarkers of survival in glioma epidemiology
Immune Impact on Cancer Chemoresistance
Immuno and Epigenetics of Hematopoietic Cell Transplantation
Immunologic Targeting of Developmentally-Regulated Antigens for the Treatment of High-Risk Medulloblastoma
Immuno-PET imaging of high-grade neuroendocrine lung tumors using 89Zr-rovalpituzumab, a DLL3-targeting monoclonal antibody
Implantable iontophoresis chemotherapy delivery device for direct infusion of gemcitabine into pancreatic adenocarcinoma: Device development and First-in-Human clinical trial
Implementing Universal Lynch Syndrome Screening across Multiple Healthcare Systems: Identifying Strategies to Facilitate and Maintain Programs in Different Organizational Contexts
Implications of Metabolic Regulation of BCL-2 Dependence for Myeloma Therapy
Improving Adverse Event Reporting on Cooperative Oncology Group Trials
Improving delivery of paclitaxel to ovarian cancer via expansile nanoparticles
Improving the disposition of antileukemic asparaginase after drug-induced immunotoxicity
Improving the radiation therapeutic ratio by inhibiting proinflammatory cytokines
In vivo anti-PD1 gene therapy
In Vivo Functional Analysis of Chromosome 7q22 Deletions in Myeloid Malignancies
Inducible systems for studying liver tumor mainenance in vivo
INHANCE Consortium
Inhibition of Stromal-Derived DKK3 to Enhance the Response of Pancreatic Cancer to Immunotherapy
Instructive role of MLL fusion proteins in lineage determination and leukemogenesis
Integrated exosomes profiling for minimally invasive diagnosis and monitoring of cancer
Integrative Analyses to Identify Pancreatic Cancer Susceptibility Genes
Integrative bioinformatics and functional characterization of oncogenic driver aberrations in cancer
Integrative genomic framework for dissecting regulatory mechanisms underlying hepatocellular carcinoma
Interplay between Dietary Fiber and Gut Microbiota in Hepatocellular Carcinoma
Interrupting Cellular Crosstalk in the Immunosuppressive Microenvironment of Pancreas Cancer
IRF2BP2 modification by Cdk5 modulates interferon-gamma response tumor PD-L1 level
Isolation, characterization and translational development of glioma stem cells
Isozyme-selective ALDH Inhibitors for Sensitizing Ovarian Cancer Stem-like Cells to Chemotherapy
KLF6: A driving factor of lung adenocarcinoma
K-Ras sumoylation in cell proliferation and transformation
Label free microfluidic isolation, characterization and ex vivo expansion of CTCs
Large aperture and wideband modular ultrasound arrays for the diagnosis of liver cancer
Late Effects Prediction using Clinical Phenotypes and Whole Genome Sequencing
LETSSGo: Lymphoma-on-chip Engineered Technology for Single-Organoid Sequencing and Genomics
Leukemia stem cell polarity and differentiation therapy
Longitudinal, multimodal assessment of neuropsychological functioning in children diagnosed with high-risk acute lymphoblastic leukemia (HR-ALL): Using early changes to predict later impairment
Macrophage-based ovarian cancer immunotherapy
Manipulation of three-dimensional chromatin structure to regulate oncogenes in breast and ovarian cancer.
Master Regulatory MicroRNAs in Glioblastoma
Mechanism and Function of Mitophagy Regulation by HHV-8 Viral Interferon Regulatory Factor-1
Mechanism of IL-10 protective effect in development of childhood B cell acute lymphoblastic leukemia
Mechanism-based approach to combine histone deacetylase inhibitors with PARP inhibitors for therapy in AML
Mechanism-based drug repurposing and novel treatments for glioblastoma
Mechanisms mediating resistance to ibrutinib in Non-Hodgkins lymphoma
Mechanisms of Formation and Progression of Preleukemic Stem Cells
Mechanisms of KLF4 suppression in pediatric leukemia
Mechanisms of Oral Cancer Inhibition by Bioactive Phytochemicals in Black Raspberries
Mechanisms of Response and Resistance to Immune Checkpoint Inhibitors in Lung Adenocarcinoma
Mechanistic Dissection of an Arginine Methyltransferase Dependency in Cancer
Memantine for Prevention of Cognitive Late Effects in Pediatric Patients Receiving Cranial Radiation Therapy for Low Grade Glioma
Metabolic basis of B cell lineage leukemia relapse
Metabolic Regulation of Tumor Progression, Metastasis and Chemoresistance by SIRT5/ELK3 signaling in Pancreatic Cancer
Metabolic rewiring regulates cancer growth and tumor-associated immune responses
Metabolic Tumor Suppressors in Renal Cancer: Unprecedented Roles in Disease Progression
Metformin Supplementation for Ovarian Cancer Prevention: A Prospective Preclinical Study
Mitochondrial Dynamics in Brain TumorInitiating Cells
Mobile app for positive psychology intervention to enhance smoking cessation outcomes
Modeling Mdm2- and 12q amplicon-driven sarcoma
Modulation of Immune Checkpoints by Self-Deliverable RNAi for Adoptive Cell Transfer
Molecular Beacon Based Extracellular mRNA and Protein Detection for Early Cancer Diagnosis
Molecular characterization and targeting of NT5C2 mutations in acute lymphoblastic leukemia
Molecular diagnostic and prognostic signatures for PTCL
Molecular Imaging and Theranostics of Cancer
Molecular Imaging Methods for the Detection of Pancreatic Ductal Adenocarcinoma
Molecular Mechanism and Therapy for Ocular Melanoma
Molecular Mechanisms in Gastrointestinal Stromal Tumor
Molecular mechanisms of Nutrient sensing in cancer
Molecular Mechanisms Underlying Environmental Effects that Influence Penetrance in Lynch Syndrome-Associated Endometrial Cancer
Molecular pathways and targeted therapies in human leukemia
Molecular regulation and therapeutic targeting of the TSC signaling network
Molecularly-Targeted Ultrasound in Ovarian Cancer
Mouse models to discover new drivers of medulloblastoma
MR-Guided Focused Ultrasound Combined with Immunotherapy to Treat Malignant Brain Tumors
MUC16 in Pancreatic Cancer Progression and Metastasis
Multi-Modal Imaging of Psychostimulant Effects on Executive Function Post-RRSO
Multiplex FRET Imaging of Kinase-Epigenome Interregulations in Live Cancer Cells
Multispecies Comparison of the Impact of Obesity on GVHD/GVT
MUTANT AND WILD TYPE WT1 IN AML
MYB family alterations in pediatric gliomas
MyD88-dependent mechanisms of Helicobacter pylori-induced gastric cancer progression
Nanovaccine platforms to combat pancreatic cancer
New DNA repair alterations in hereditary cancer development
New Therapeutic Targets in Small Cell Lung Cancer that are Epistatic or Synthetic Lethal with pRB Loss
NFAT activation in kGPCR tumorigenesis
Nicotinamide N-Methyltransferase (NNMT) as a master regulator of cancer stroma
Non-canonical WNT signaling in the invasion and metastasis of uveal melanoma
Noncoding RNA Biomarkers for Noninvasive and Early Detection of Pancreatic Cancer
Noninvasive prediction of tumor response to gemcitabine using MRI
Normal ABL1 kinase as tumor suppressor and therapeutic target in leukemia
Notch signaling in liposarcoma
Novel combined immunotherapeutic strategies for glioma: using pet dogs as a large animal spontaneous model
Novel DNA Repair Inhibitors for Cancer Therapy
Novel Glyco-tests to Predict Chemoresistance
Novel Inhibitors of PSMB7 and PSMB10 for the Treatment of Multiple Myeloma
Novel mechanisms and therapeutic strategies of refractory leukemia
Novel model to study PDAC using normal human pancreatic tissue
Novel monobody therapy for pancreatic cancer
Novel Nanodrug Delivery System to Optimize Dose of Oncology Drugs
Novel Nano-Plasmonic Technology for Quantitative Analysis of Cancer Exosomes
Novel Relationships between BER Glycosylases and Mutagenic DNA Adducts
Novel targeted therapeutic for advanced metastatic disease
Novel targeted therapies for isocitrate dehydrogenase mutantcholangiocarcinoma
Novel therapeutic approaches for enhancing anti-tumor immunity in SCLC
Novel Therapeutic Approaches for the Treatment of Rhabdomyosarcoma
Nucleotide Metabolism in Senescence and Platinum Resistance of Ovarian Cancer
Obesity Increases Breast Cancer Penetrance in BRCA Mutation Carriers: A Role for Local and Systemic Factors
Omics Approach to Interrogating Mechanism of ETV5 in Glioma
Oncogenic Disruption of the Circadian Metabolic Cycle in Cancer
Oncogenic pathways and therapeutic targets in T cell acute lymphoblastic leukemia
Oncogenic programs driven by notch signaling in B-cell lymphoma
Optical and electromagnetic tracking guidance for hepatic interventions
Optical imaging guided resection and photodynamic therapy of glioma with targeted photoactivable agents
Optical imaging of pancreas cancer organoids for drug development and personalized treatment
Optimizing Delivery of Oncolytic Measles Virus Strains with Cell Carriers
Optimizing Hematopoietic Stem Cell Transplantation for the Treatment of Hematological Malignancies
Optimizing Novel Immunotherapy Combinations Targeting the Tumor Microenvironment in Canine Spontaneous Osteosarcoma
Optimizing the Treatment of Pancreatic Adenocarcinoma
Oral formulation for novel inhibitor of Ras driven cancers
Organic nanoparticles for dual MRI-guided therapeutic selection and ovarian cancer drug delivery
Osteopontin-targeted therapy for primary CNS lymphoma
Overcoming resistance in BCR-ABL-rearranged acute lymphoblastic leukemia
Pancreatic Cancer Detection Consortium
Pancreatic Ductal Adenocarcinoma Translational Resource Center (PATReC)
Pathophysiological role and therapeutic potential of microRNA-29 in pancreatic cancer autophagy
Patient-centered leukemia diagnostic and monitoring using the HemoLink-MD
Patient-derived glioblastoma in vitro and in vivo studies of tryptophan metabolism via the kynurenine pathway
Patient-Matched Stem Cells of the Barretts-Dysplasia-Adenocarcinoma Sequence
PATTERNS OF r AAV VECTOR INSERTION ASSOCIATED WITH LIVER TUMORS IN A MOUSE MODEL
PD-1 blockade with cryoablation and dendritic vaccine to treat lymphoma
PDGFR beta signaling in the tumor microenvironment of metastatic breast cancer
PDL1 expression on B cells: a potential marker of pre-tumor cells in AIDS-NHL
Peptide-based targeted molecular imaging for early detection in pancreatic cancer
Personalized cancer models to discover and develop new therapeutic targets.
pH Transistor Nanoprobes for Detection of Occult Nodal Metastases
Phase 3 Study of SGX301 and Fluorescent Light for Cutaneous T Cell Lymphoma
Phenotype Transitions in Small Cell Lung Cancer
Physiological Role of Dynamin-Related Protein 1 in Pancreatic Ductal Adenocarcinoma
Potential Role of the Novel Angiopoietin-like Protein RIFL/Angptl8 in Hepatocellular Carcinoma
PQ6: Role of Cellular Senescence in Late Effects of Childhood Cancer Therapy
Precision Assessment and Delivery of Cancer Risks in BRCA 1/2 Mutation Cancers
Preclinical development of a DLL3-targeted theranostic for small cell lung cancer
Primers: Combining Radiotherapy and Immunotherapy using next genertaion radiotherapy biomaterials
Probing the role of a highly expressed lncRNA in hepatocellular carcinoma
Probing the role of the IRE1alpha-XBP1 pathway in normal and malignant hematopoiesis
Prodrug treatment for CML
Programa de ARBOLES Familiares: Assessing Risk of Breast Cancer through Outreach to Latinas with Education and Support
Protease activated receptor-2 (PAR-2) signaling and metastatic ovarian cancer
Proteasomal regulation of BMI-1 and impact on tumor initiating cells in glioblastoma
Protein and proteolytic activity biomarkers of early stage pancreatic cancer
Proteogenomic studies aimed at understanding ovarian tumor responses to agents targeting the DNA damage response and translating this knowledge into clinical benefit
Proteogenomic Translational Research Center for Clinical Proteomic
Proteomics of Metastatic and Non-Metastatic Uveal Melanoma
Quantifying Multiscale Competitive Landscapes of Clonal Diversity in Glioblastoma
Quantitative imaging tools to derive DW-MRI oncological biomarkers
Quantitative Non-Contrast Perfusion using Arterial Spin Labeling for Assessment of Cancer Therapy Response
Quantitative Staging and Therapeutic Response in IDH-1 Mutated Glioblastomas
QuBBD: Precision E –Radiomics for Dynamic Big Head & Neck Cancer Data
Raising the Therapeutic Index of Photodynamic Therapy with Targeted Nanosyringes
Rapid detection of minimal residual disease in acute myeloid leukemia from peripheral blood
Rapid unbiased isolation and in situ RNA analysis of circulating tumor cells using a magnetic micropore-based diagnostic chip
Rational Translation of EZH2 Targeted Therapy in Germinal Center B-cell Lymphoma
Reconstituting human pancreatic cancer development for translational research
Reengineering obesity-induced abnormal microenvironment to improve PDAC treatment
Regulation of c-myc translation by hnRNP A1: Role in multiple myeloma tumor responses
Regulation of Pancreatic Oncogenesis by the Gut Microbiome
Regulation of TAL1/SCL in T-Cell Leukemia
Regulation of tumor growth and metabolism by hyperinsulinemia
Regulatory role of long noncoding RNAs in normal and cancer cells
Reprogramming PDAC tumor microenvironment to improve immunotherapy
Reprogramming Tumor-Associated Macrophages in PDAC with MicroRNA Nano-Vectors
Resistance To Targeted Immunotherapies:CART19 as a Paradigm
Resolving the obesity paradox in kidney cancer
Retrospective NCI Phantom-Monte Carlo Dosimetry for Late Effects in Wilms Tumor
Retroviral Replicating Vector-mediated Gene Therapy for Ovarian Cancer
RNF128 Regulation of TP53 in Barretts Progression
Robust Predictor of Breast Cancer Risk
Role of autophagy in normal and transformed hematopoietic stem cells
Role of CRABP-II in pancreatic cancer metastasis
Role of ER stress-driven IRE1α-XBP1 Signaling in Lung Cancer Pathogenesis
Role of hedgehog signaling in tumor-associated macrophage polarization
Role of long non-coding RNAs in sarcoma pathogenesis
Role of m6A mRNA methylation in Neuroblastoma
Role of MAST1 kinase in cisplatin resistant cancers
Role of microbiota in therapy to ovarian cancer
Role of microRNAs released by Tumor Associated Macrophages within Exosomes in the chemoresistance of Neuroblastoma
Role of MIF in myeloma bone homing and drug response
Role of mismatch repair in regulating effects of PARP inhibition in Glioblastoma
Role of p62/SQSTM1 in obesity-induced liver cancer
Role of PD2/Paf1 in Pancreatic Acinar to Ductal Metaplasia
Role of PTEN and PI-3 kinase in medulloblastomagenesis
Role of the hexosamine biosynthesis pathway in pancreatic cancer.
Role of the Histone Methyltransferase MLL4 in Medulloblastoma
Secondary Chemoprevention of Oral Cancer by Locally Delivered Agents
Self-expanding hydrogel for pelvic brachytherapy: a novel method for vaginal packing and customized radiation therapy
Sensitization to Chemoradiation by Therapeutic Targeting of the DNA Damage Response
Sequence variation in mtDNA and extreme survival in glioblastoma
Sequestration and deactivation of anthracycline by adipocytes in the leukemia microenvironment
Serotonin drives cancer stem cell maintenance and glioblastoma progression
Seventeenth Annual Meeting of the Rocky Mountain Virology Association
Simultaneous Detection of Proteins and Whole Transcriptomes in Single Cells
Single-cell analysis of tumor-microenvironment interactions in follicular lymphoma
Single-molecule mechanical detection of protein and microRNA cancer biomarkers
Sirolimus Delivery from Esophageal Stents to Prevent Scarring after Mucosectomy
Small-molecule MDM2 degraders
SMART-ACT: Spatial Methodologic Approaches for Risk Assessment and Therapeutic Adaptation in Cancer Treatment
Smartphone Enabled Point-of-Care Detection of Serum Markers of Liver Cancer
Spectroscopic MRI to guide radiation dose escalation for glioblastoma patients
Sphingosine-1-phosphate receptor subtype 3 in oncogenic K-Ras mutant-driven lung adenocarcinoma
SQSTM1/p62-targeted Small Molecules for Multiple Myeloma Disease
STAT3, G6PD and TrxR as underlying mechanisms for antitumor responses to hirsutinolides
State of the Science: Healthy Weight Maintenance During Pediatric, Adolescent, and Young Adult Cancer Treatment
Statin Intervention to Slow the Time to Hepatocellular Carcinoma Recurrence in Cirrhotics Awaiting Liver Transplantation
Statistical Methods for Characterizing Tumor Heterogeneity at the Single Cell Level
Steady states and cellular transitions associated with carcinogenesis and tumor progression
Stem Cell Biology, Cancer Stem Cell Biology, and Cancer Immunotherapy
Stroma targeted theranostic nanoparticles for pancreatic cancer
Structural biology and drug discovery targeting oncogenic EGFR and BRAF kinases
SWI/SNF complex in mouse HCC development
Syndecan-1 (CD138) and its synstatins: targeting invasion, survival and angiogenesis in myeloma
Synergistic role of signaling and epigenetics in leukemic transformation
Synthetic and Mechanistic Studies of Myrocin Antitumor Agents
Systematic interrogation of the pancreatic cancer microenvironment in patient-derived specimens
Systemic RNA interference to reactivate p53 tumor suppression
T antigens inhibit Notch to promote Merkel cell carcinoma in skin stem cells
Targeted activation of autoimmune checkpoints in B cell malignancies
Targeted Molecular Imaging of Plectin-1; Bench to bedside and back again
Targeted therapeutics for ovarian cancer and its microenvironment – treatment and theoretical modeling
Targeted Therapies for Richters Transformation
Targeting CDK4/6 for pancreatic cancer treatment
Targeting CK2 oncogenic pathway to overcome drug resistance in high-risk leukemia
Targeting c-Myc and Proteasome Inhibitor Resistance in Multiple Myeloma
Targeting Cyclin E in Ovarian Cancer with Histone Deacetylase Inhibitors
Targeting cysteine import to induce ferroptotic cell death in pancreatic cancer
Targeting DEPTOR in multiple myeloma
Targeting DNA Base Excision Repair in Acute Myeloid Leukemias
Targeting Human Cancers with Hemizygous Deletion of TP53
Targeting hyaluronan in the tumor microenvironment to improve DNA vaccine immunotherapy
Targeting hyaluronan synthesis and signaling with BET inhibitors in pancreatic cancer
Targeting inflammation and immune response in HNSCC therapy
Targeting Kidney Cancer-associated CD105 expression with a novel Listeria-based Vaccine Approach
Targeting Kinesin Family Member 15 for the Treatment of Cancer
Targeting Lysine Methyltransferases EZH2 and EZH1 for Treating MLL-rearranged Leukemias
Targeting macrophages to sensitize myeloma to immune checkpoint blockade
Targeting Mdm2-MdmX E3 Ligase for Treatment of Drug-Resistant Lymphoma
Targeting metabolic vulnerabilities in glioblastoma
Targeting microRNAs to eradicate leukemia stem cells
Targeting novel DAMP mediated signaling pathways to mitigate GVHD
Targeting TET1 signaling to treat acute myeloid leukemia
Targeting the ARHGAP25 pathway in acute myelogenous leukemia stem cells
Targeting the GFI1-LSD1 Axis in T-Cell Acute Lymphoblastic Leukemia
Targeting the p62 signalosome in leukemia.
Targeting the TGIF/Twist1 network in osteosarcoma
Targeting the transcriptional and epigenetic landscape in chemo-refractory Small-Cell Lung Cancer
Targeting Transcriptional Regulators for Immunotherapy of Acute Myeloid Leukemia
Targeting VCAM1-a4b1 Signaling to Ameliorate Pulmonary Osteosarcoma Metastasis
Targeting Wnt signaling to overcome PARP inhibitor resistance in ovarian cancer
The cohesin complex as a tumor suppressor in myeloid leukemia
The Development And Progression Of IPMN To PDA In The Context Of Inactivated Activin Signaling
The Effect Of Cohesin Mutations In Hematologic Malignancies
The epigenetic mechanisms of high-grade pediatric glioblastoma
The Impact of Maternal Obesity on the Reprogramming of the Metastatic Microenvironment
The Influence of Social Network Size, Composition and Function on Psychological Outcomes of Pediatric Cancer Caregiving: Relationships across Time and around Periods of Distress
The molecular basis of IMiD induced neo-substrate recruitment to the CRL4CRBN ubiquitin E3 ligase.
The molecular mechanisms of metabolism reprogramming in mutant Kras/Ink4a-driven pancreatic ductal adenocarcinoma
The mRNA methylation program in leukemia
The Novel Role of REST in the Development of Pancreatic Ductal Adenocarcinoma
The Pancreatic Cancer Microenvironment
The role and mechanism of FTO in leukemogenesis and drug response
The role of AID/APOBEC3 proteins in genome instability in multiple myeloma
The Role of CD147 in Glioblastoma Invasiveness
The Role of DLST in Leukemogenesis
The role of DNMT3A in gene regulation and stem cell expansion
The role of histone demethylases in acute myeloid leukemia cell persistence
The Role of Inflammation in the Racial Disparities in Ovarian Cancer Survival
The Role of ITIH5 in Suppressing Pancreatic Cancer Metastasis
The role of JMJD6 in MYC-mediated neuroblastoma
The role of neuroendocrine transdifferentiation of pancreatic cancer cells on tumor progression and chemoresistance.
The role of p120ctn in PDAC epithelial-to-mesenchymal transition and metastasis
The role of PLAG1 in Wilms tumor formation
The role of short-form Ron (sfRon) kinase in the pathogenesis of high-grade serous ovarian cancer
The Role of Splice Quantitative Traits in Ovarian Cancer Pathogenesis
The Role of Suv420h1 Histone Methyltransferase in MYC-Driven Tumorigenesis
The Role of the miRNA Cluster at 14q32 in Lipid Regulation and Renal Cancer Biology
The role of TIM3 and CEACAM1 in anti-tumor function of human effector T cells
The role of X chromosome inactivation in ovarian cancer
The SMYD3-ERK5 signaling module in pancreatic cancer
The Unfolded Protein Response in Glioblastoma
Therapeutic disruption of Connexin43-mediated microtubule regulation to target glioblastoma cancer stem cells
Therapeutic miRNA Modulation of Hepatocellular Carcinoma Using Ultrasound Guided Drug Delivery
Therapeutically Exploiting a Newly Isolated Neural-Like Stem Cell Against GSB
Thrombin-dependent mechanisms of pancreatic ductal adenocarcinoma disease
Tools to Measure Non-Receptor Tyrosine Kinase Activities for Drug Discovery and Biomarker Analysis
Transcriptional Regulation of Lung Cancer Identity
Translating genomic discoveries to improved outcomes for high risk acute leukemia
TRANSLATING NK CELL BIOLOGY INTO CLINICAL CANCER IMMUNOTHERAPY
Trans‐nasal delivery of chemotherapy to glioblastoma using magnetic nanoparticles and magnetic focusing
Tumor Molecular Profiling and Response to Immunotherapy in Advanced Biliary Cancers
Tumor suppressor roles of E2F7 & E2F8 in hepatocellular carcinoma
Tumor-targeted nanoparticle-based delivery system for imaging and treatment of cancer
U2C Kids First Admin Supplement – cloud-based data storage and compute
Ultra-High Content Analysis (UHCA) of Single Cells in Tissue: 60+ channel immunofluorescence labeling kits and companion imaging software for everyone
Ultrasensitive Quantitation of Circulating Tumor DNA
Ultrasound-Based Device to Guide Treatment of Graft-Versus-Host-Disease Using Skin Elasticity as a Biomarker
Uncovering Role of Exosomes in Regulating Pancreatic Cancer Cell Metabolism
Uncovering the Role of Colorectal Stem Cells on Disease Penetrance in Lynch Syndrome
Understanding How Ciliary Hedgehog Signaling Causes Medulloblastoma
Understanding metabolic pathways that support redox homeostasis in cancer
Understanding neuropsychological and psychosocial sequelae in the elderly and in adolescent and young adult cancer survivors
Understanding succinate-induced global transcriptional and epigenetic reprogramming and identifying unique vulnerabilities intrinsic to SDH-deficient cells
Understanding the consequences of oncogenic mutations on FGFR signaling
Use of chromatin accessibility maps to discover novel regulatory circuits in aggressive B cell lymphomas
Using microfluidic single cell culture to characterize cancer cell asymmetric division
Using Single Cell Analysis to identify therapeutic vulnerabilities in leptomeningeal melanoma metastases
Vitamin D and Follicular Lymphoma
White Matter Toxicity and Neurocognitive Outcomes in Pediatric Brain Tumor Patients Treated with Proton Beam Radiation Therapy
Wiskott-Aldrich syndrome protein (WASp) signaling in the oncogenesis of T cell lymphomas
Wnt/?-catenin Signaling in Pancreatic Oncogenesis
2016
(10.) The Gut Microbiome and Responses to Neoadjuvant Chemoradiation in Rectal Cancer Patients
(9) Biophysical Description of Age and Dose Dependent Changes to Dendritic Morphology that Impact Cognition following Radiation Cancer Therapy
(PQ 6) Exploiting Frequent Alterations in the PRC2 Complex to Distinguish Benign Neurofibromas from Malignant Peripheral Nerve Sheath Tumors
(PQ 9) Synaptic basis of deficits in attention and executive function following cranial radiation
(PQ1) Characterization of Premalignant Fields in a Murine Model of Head and Neck and Esophageal Cancers
(PQ1) Genomic characterization of mesenchymal stromal cells in Monoclonal Gammopathy of Undermined Significance (MGUS)
(PQ1) Progression of the airway field of injury to Kras mutant lung cancer
(PQ11) Reversing exosome-mediated immune suppression – a novel strategy for cancer therapy
(PQ11) Targeting STING in the context of chemoradiation therapy to overcome poor preexisting immunity in mouse models of pancreatic cancer.
(PQ2) HIV INFECTION, APOBEC UPREGULATION, AND CANCER MUTAGENESIS
(PQ3) Identifying Novel Pharmacologic Risk factors for Common Non-AIDS Defining Cancers in Individuals with Well-controlled HIV Infection
(PQ3) Modulation of Osteosarcoma Biology by Inflammation and Immunity Defined through a ComparativeApproach
(PQ4) Mutations in the histone chaperone DAXX drive pancreatic neuroendocrine tumors not ductal adenocarcinomas
(PQ4)HIV and Aging Mechanisms for Hepatocellular Cancer
(PQ5) Mitochondria in Leukemic Stem Cell Disease Progression
(PQ7) In Vivo Cellular Optical Imaging of Esophageal Tumors and Microenvironment
124I-NaI PET: Building block for precision medicine in metastatic thyroid cancer
15-PGDH in Cholangiocarcinogenesis
2016 AUA Urologic Oncology Research Symposium: Forging New Paths in Research to Advance Urologic Oncology”
2016 Lysosome and Endocytosis Gordon Research Conference & Gordon Research Seminar
2D and 3D Contrast-enhanced Ultrasound Evaluation of HCC Chemoembolization
A CEST-MRI Reporter Gene for Image Guided Oncolytic Virotherapy
A Clinical Validation Center for Early Detection of Pancreatic Cancer
A clinically-relevant anti-CD27 agonist antibody as a vaccine adjuvant for brain tumor immunotherapy
A high content screen dissecting ciliogenesis and oncogenic Hedgehog signaling
A Multimodal Imaging Strategy for Preclinical Optimization of Anticancer Nanomedicines
A network platform to connect drug response and prognosis phenotypes for cancers
A New Small Molecule Targeted Therapeutic for Acute Myeloid Leukemia
A novel oncogenic driver in Ewing sarcoma
A Novel Oncogenic Role for Cdc20 Implications in Adult T Cell Leukemia Treatment
A Novel Oral Therapeutic for Hepatocellular Carcinoma (HCC)
A Novel Strategy Targeting TfR1 for the Prevention/Treatment of AIDS-related NHL
A Phase I Dose-escalation Study of Intraperitoneal CYN101 as Consolidation Immunotherapy in Women with Residual or Recurrent Ovarian Cancer Status after Chemotherapy
A rapid spontaneous murine model of CN-AML
Aberrant signaling in acute myeloid leukemia
ADAM8 Is a Novel Target for Treatment of Triple-Negative Breast Cancer
Adipocytes are Important Players in the Acute Lymphoblastic Leukemia Microenvironment
Advanced Development and Validation of 3 Dimensional Spheroid Culture of Primary Cancer Cells using Nano3D Technology
Algorithms for Literature-Guided Multi-Platform Identification of Cancer Subtypes
Allogeneic antibody therapy for malignant mesothelioma
Analysis and Therapeutic Targeting Non-proteolytic Protein Ubiquitination in Diffuse Large B Cell Lymphoma
Analysis of TET2 function in acute leukemia
Anti-CD138-IFN fusion proteins for the immunotherapy of multiple myeloma
Anti-CTGF Therapy for Squamous Cell Lung Cancer
Augmented homologous recombination as a mechanism of acquired temozolomide resistance in glioblastoma
Balancing Efficacy and Toxicity of Intratumoral Reolysin for Diffuse Intrinsic Pontine Glioma (DIPG)
Behavioral Influences on Ovarian Cancer Progression: Role of Chemoresistance
beta1 integrin/c-Met: a receptor complex driving invasive resistance to anti-angiogenic therapy in glioblastoma
Biochemical and Functional Characterization of the Mutagenic Cytidine Deaminase APOBEC3B in the contextof Squamous Cell Lung Carcinoma
Biologic and Preclinical Studies of Myeloid Malignancies
Biologic and therapeutic relevance of DNMT3A mutations in acute myeloid leukemia
Biomimetic hydrogel niches to study the malignant phenotype of glioblastoma multiforme
Blocking NK cell shedding of CD16a to increase cancer cell killing
BM NICHE DISRUPTION AND IMMUNOTHERAPY IN HEMATOLOGICAL MALIGNANCIES
Brain Tumor Epidemiology Consortium
Canadian Fluoroscopy Cohort Study: Lifespan Mortality and Incidence Follow-Up
Cancer-Associated Fibroblasts Alter the Composition of B cells in Solid Malignancies
CAR-T cell control through orthogonal antibody-based switches
Cytokine-induced RelB phosphorylation in glioblastoma multiforme
Deciphering the role of Lin28b in pancreatic cancer to guide therapeutic discovery
Defective Myoblast Fusion Signaling in Rhabdomyosarcoma Pathogenesis
Defining epigenetic vulnerabilities of subtype-specific lung cancers
Defining Monoclonal Gammopathy of Unknown Significance in Automated Health Data
DEFINING RISK FACTORS FOR NF1-OPTIC GLIOMA
Defining the formation and function of carcinoma-associated mesenchymal stem cells in the ovarian cancer microenvironment
Defining the Germline Genomic Landscape of a Novel GIST Multi-tumor Syndrome
Delineating roles for a novel tri-protein complex (TRIM44) in the multiple myeloma stem cell niche
Design and synthesis of stabilized pironetin analogs for the treatment of resistant ovarian cancers
Designing durable apoptosis-targeting therapies for acute myeloid leukemia
Determinants of acquired resistance in small cell lung cancer
Determinants of pancreatic cancer and malignant melanoma phenotypes in CDKN2A hereditary kindreds
Determining the Role of BCOR Mutations in Myeloid Malignancies
Determining the Role of Metabolism in Resistance in Acute Myeloid Leukemia
Determining the Role of Tumor-Associated Macrophages in oHSV Antitumor Efficacy in Ewing Sarcoma and Rhabdomyosarcoma
Deubiquitinases in regulation of BRCA1 pathway
Developing a translational pipeline for NF1-mutant malignancies
Developing Therapy for the Treatment of Cholangiocarcinoma
Development and testing of MRI-mediated radiofrequency ablation system and probes
Development of 18F-based Pretargeted PET imaging strategies for the PET imaging of cancer
Development of a mouse model of pediatric high-grade gliomas
Development of an LXR agonist as first in class therapy for treatment of metastatic melanoma
Development of Casein Kinase 1d and 1e Inhibitors for Treatment of Brain Cancer
Development of cell-free DNA assays for HCC screening and liquid biopsy
Development of DNA Polymerase θ Inhibitors for Precision Medicine in BRCA Deficient Cancers
Development of in vitro diagnostic multivariate index assay using liquid-based cervical cytology specimen and/or serum/plasma biomarkers for the detection of early stage or low-volume ovarian cancer
Development of multifunctional biodegradable drug-loaded polymer stents for inoperable esophageal malignancies
DEVELOPMENT OF NOVEL CHEMICAL PROBES TO MAP S-NITROSYLATION IN CANCER
Development of novel selective Rac inhibitors for refractory leukemias
Development of novel therapies for megakaryocytic malignancies
Development of Parametric Response Mapping Software for Clinical Cancer Response Assessment
Development of Quinoxaline Based IKKbeta Inhibitors for Kras Driven Cancers
Development of small molecules targeting Ring1B-Bmi1 E3 ligase in leukemia
Development of Targeted Nanotechnology Platform for Pancreatic Cancer
Development of Transporter Targeted Platinum Drugs for Glioblastoma
Developmental studies to inform clinical stratification and targeting of SHH MB
Digital Analysis of Plasma miRNA populations in Pancreatic Cancer
Dim light at night alters pancreatic cell signaling and predisposes to pancreatic adenocarcinoma
Discovery and Characterization of Mutations in Breast and Ovarian Cancers
Discovery and Characterization of New Human Cancer Viruses
Discovery of pathogenic germline variants in pediatric cancers using genomics.
Disrupting tumor/bone malignant interactions with multifunctional cytokine sonodelivery
Dissecting gastric cancer clonality with genomic analyses and patient xenografts
Dissecting mechanism(s) by which ionizing radiation promotes clonal expansion of premalignant cells in the thymus
Dissecting the molecular and functional role of Sox2 in synovial sarcoma
Drosophila as a low complexity model for human neoplasms
Early Detection of Hepatocellular Carcinoma
Early detection of ovarian cancer by serum marker and targeted ultrasound imaging
Early Detection of Ovarian Cancer Through Epigenetic Factors in the WHI
Early Stage Diagnosis of Kaposis Sarcoma in Limited Resource Settings using KS-Detect
e-Assist: A Post-Visit Patient Portal Tool to Promote Colorectal Cancer Screening
Ect2 Function in Lung Adenocarcinoma Initiation and Maintenance
Elucidating and exploiting the mechanisms by which IL-6 and IL-8 facilitate osteosarcoma metastasis
Elucidating KRAS-specific vulnerabilities in pancreatic cancer
Elucidating the role of the Nrf2 anti-oxidant pathway in lung adenocarcinoma
Enhancing anti-neoplastic activity of metformin in prostate cancer
Enhancing at-Risk Latina Womens Use of Genetic Counseling for Hereditary Breast and Ovarian Cancer
Enhancing Cancer Immunotherapy: Targeting the Tumor and Targeting the Host
Enhancing immune therapy in pancreatic cancer by targeting IL-6
Epidemiology and biology of lncRNAs in ovarian cancer
Epigenetic activity of normal and cancer-associated mutant H1 linker histones
Epigenetic mechanisms for oncogene silencing in MLL-rearranged leukemia
Epigenetic Mechanisms of Oncohistone Detoxification
Epigenetic Modulation of Wnt/Beta-catenin Pathway and Tumorigenesis of Glioma Cells by KDM4C
ER stress and UPR in non-alcoholic steatohepatitis and hepatocellular carcinoma
ERASE – A new dual thermal ablation/SCN device system for treating pancreatic cancer
ESTABLISHING A CONDITIONAL TELOMERASE KNOCK-IN ALLELE IN A HAPLOID CANCER CELL LINE TO IDENTIFY REGULATORS OF ALT THROUGH GENETIC FORWARD SCREENS
Evaluation of Bruton’s Tyrosine Kinase and p110 delta in Mutant Shp2-Induced JMML
Evolutionary Heterogeneity of High Grade Glioma
EWS/FLI Regulates Transcriptional Activation in Ewing Sarcoma via Length Dependent GGAA Microsatellites
Examining the role of normal hematopoiesis in supporting incipient myelodysplasia
Examining the role of the miR-181a:Wnt/B-catenin axis in ovarian cancer
Exosomic microRNAs and drug resistance in AML tumor microenvironment
Exploiting Altered Porphyrin Synthesis for Metabolic Imaging of Glioblastoma
Exploiting Caveolae-Dependent Albumin Endocytosis to Optimize Therapy in Pancreatic Cancer
Exploring BCL-XL addiction in pancreatic ductal adenocarcinoma
Exploring Glycobiology and Discovering Biomarkers for Pancreatic Cancer
Exploring oncogenic translation programs in cancer
Exploring the Role of Mitochondrial Fission in Pancreatic Tumorigenesis
Extracellular DNA in regulation of multiple myeloma
Fate and efficacy of targeted therapies for metastatic tumors
Fgl-2 targeted therapy for reversing multi-modality immune suppression
First in-human PET imaging studies of NIS reporter [18F]BF4
Foregut Microbiome and Risk of Gastric Intestinal Metaplasia, and Gastric Cancer Risk
FOXM1-RHNO1 Oncogenic Axis in Ovarian Cancer
From pathogenesis to new therapeutic targets in Diffuse Large B cell Lymphoma
Functional Characterization of Glioma GWAS Variants
Functional Dissection of the K27M Histone Mutation In Gliomagenesis
Functional Interrogation of Kdm6a-Dependent Tumor Suppression during Pancreatic Cancer
Functions of BNIP3 in lipid metabolism in the liver and in hepatocellular carcinoma
Gastrointestinal Meeting on Intestinal Metaplasia in the Esophagus and Stomach
Genetic Cytology for Ovarian and Endometrial Cancer Screening
Genetic Epidemiology of non-Hodgkin Lymphoma
Genome-edited uveal melanoma cell lines for investigating constitutively active GNAQ and GNA11
Genomic approaches to guide molecular classification of glioma
Genomic Heterogeneity and the Small Renal Mass
Genomics and Mechanisms of Esophageal Carcinogenesis
Glial tumor image-guided surgery and treatment
Glioblastoma, Glioblastoma Stem Cells and Radiotherapy
Gold Nanoparticle Treatment of Glioma
Gut-Related Markers and Hepatocellular Cancer in a Multi-Ethnic Cirrhotic Cohort
Harnessing Host Response to Prevent Myeloma
Harnessing the Immunologic Capacity of RNA-nanoparticle Vaccines Targeting Glioblastoma
Health Services Career Development: Improving Medical Decisions in Ovarian Cancer
Hexokinase 2 in liver cancer
High Throughput Screening to Discover Chemical Inhibitors of Quiescin Sulfhydryl Oxidase 1
High-Throughput Generation of Pancreatic Organoids with Controlled Stromal Milieus using Microraft-Based Cell Sorting
Histologic and Immunohistochemical Biomarkers for Heavily Treated Metastatic Prostate Cancer.
Histone Modification and Transcription Elongation in Human Cancer
HMGB1 as Link Between Hepatocellular Injury and HCC
Host factors, tumor microenvironment and survival in a multiethnic study of Hodgkin lymphoma patients
How HTLV-I Tax and HBZ control telomerase activity to induce adult T-cell leukemia
HSC-Independent Mechanisms Underlying JMML
Humanized bone marrow-like model to study patient-derived myeloma xenografts
Hypermutation and malignant progression in an expanded cohort of TMZ treated LGG patients from different molecular subgroups
Identification of chemosensitizing agents that block DNA repair by the Fanconi Anemia/Bloom Dissolvasome complex
Identification of Long Non-coding RNAs as Novel Biomarkers for Heterogeneous Glioblastomas
Identification of non-coding RNAs to therapeutically target undruggable pathways in metastatic lung adenocarcinoma and squamous cell carcinoma
Identification of novel cooperating partners of MYCN in neuroblastoma tumorigenesis
Identifying a nodal point for G alpha q signaling in eye disease
Identifying epigenetic drivers and their targets in aggressive breast and ovarian cancers
Identifying insulin resistance biomarkers and metabolomic signature as predictors of precursors to pancreatic cancer
Identifying Mechanisms of p53 and Rb Tumor Suppression In Small Cell Lung Cancer
Identifying the biosynthesis of a potent cytotoxic agent Lasonolide A
IKK/NF-kappaB Signaling in Cancer: Therapy, Resistance, and Tumor Initiating Cells
Image-guided ultrasound therapy and drug delivery in pancreatic cancer
Imaging drug uptake and distribution in chemoradiation therapy of pancreatic cancer
Imaging Liver Cancer Proliferation
Imaging of Hematologic and Oncologic Disorders
Imaging Tumor Associated Macrophages in Bone Sarcomas
Impact of aging on the outcomes of a mouse model of chronic myeloid leukemia
Improving Sorafenib; a multi-targeted kinase inhibitor used for the treatment of hepatocellular carcinoma by mechanistically dissecting out its underlying targets and anti-targets
In vivo imaging of Stem cell loaded oncolytic viruses for cancer therapy
Inflammation and gynecologic cancer: the role of prostaglandins in ovarian cancer
Integrated Signaling in Pancreatic Cancer Progression
Integrating Transforming Approaches to Identify and Target New Vulnerabilities in Cancer
Integration of gene expression patterns, fusions, mutations, cytogenetics and other clinical variables for subtyping leukemias and targeting therapies
INTEGRATIVE IMAGING INFORMATICS FOR CANCER RESEARCH
International Registry of Werner Syndrome
Interpreting limits to nanoparticle delivery in high-stroma low-perfusion tumors
Intra-Operative, Label-Free Detection of Brain Cancer Infiltration with Quantitative Optical Imaging
Intratumor heterogeneity and therapeutic resistance
Intra-tumor Heterogeneity in Colorectal Cancer Progression and Treatment Response
Investigating L-2-hydroxyglutarate in normal hematopoiesis and leukemogenesis
Investigating the development and maintenance of tumor-associated tertiary lymphoid structures in an autochthonous mouse model of lung adenocarcinoma
Investigating the molecular mechanism that mediates the addiction of inflammatory breast cancer cells to HDAC6 function
Investigating the potential role of NADPH oxidase 2 in regulating the biology of leukemic stem cells
Investigating the Role of Chronic Inflammation in the Pathogenesis of Myeloid Malignancies
Investigating the Role of Novel Drug Target TBK1 in Pancreatic Cancer Pathogenesis
Investigating the role of RBM10-regulated alternative splicing in lung tumorigenesis
Investigating the Role of the Mek5-Erk5 Kinase Module in Small Cell Lung Cancer
Investigation and targeting of the transcriptional and epigenetic landscape of Small Cell Lung Cancer
iPGDAC, An Integrative Proteogenomic Data Analysis Center for CPTAC
Isothermal Chain Reaction (ICR) Detection of SNP Biomarkers for Ovarian Cancer Pont-of-Care Testing and Risk Stratification
JOC-x: Chemotherapy conjugates that open tumor tight junctions to treat cancer
Kinase Dependent Chemotherapy Resistance Mechanisms in Small Cell Lung Cancer
Kinase Inhibition in Kidney Cancer
Label-free microfluidic enrichment of cancer cells from noncancer cells in ascites fluid
Large Volume Intratumoral Injection Device for Therapeutic Liver Infusions
LASER TISSUE WELDING: BREACHING BARRIERS IN THE SURGICAL MANAGEMENT OF THE PANCREAS
Leukemia Specific Splice Isoforms as Neo-Antigens for T-Cell Immunotherapy
Lipoxins and aspirin triggered lipoxins in KSHV latency and pathogenesis
Loss of oncogene insulation drives IDH1 mutant glioma
Mapping cancer micro-environments for acute leukemia
Material Hardship as a Targetable Measure of Poverty in Pediatric Cancer
Maximizing cancer synthetic lethality using dual PI-3K/PARP inhibitors
Mayo Clinic Prospective Resource for Biomarker Validation and Early Detection of Pancreatic Cancer
MD Anderson Cancer Center EDRN- CVC for Early Detection of Ovarian Cancer
MDSC-tumor crosstalk in prostate cancer progression and castration resistance
Mechanism behind CCL21/CCR7-mediated pancreatic cancer progression
Mechanism of evasion by ovarian cancers from anti-VEGF therapy
Mechanism of gp96/grp94 in regulating plasma cells and myeloma
Mechanism of Ikaros Tumor Suppression in progenitor B cell leukemia
Mechanism of Met-Induced Hepatocyte Survival
Mechanism of the methyltransferase Prdm3 in MLL leukemogenesis
Mechanisms governing metastatic dormancy and reactivation
Mechanisms of c-CBL Regulation in Cutaneous T-Cell Lymphoma (CTCL)
Mechanisms of durable antitumor immunity via CD26hiCD4+ T cells
Mechanisms of Escape from TGFβ Tumor Suppression in the Pancreas
Mechanisms of Human Lymphoid Chromosomal Translocation
Mechanisms of Pancreatic Carcinogenesis
Mechanisms of PD-1 and Tim-3 crosstalk in tumor-infiltrating lymphocytes
Mechanisms of radioresistance and strategies for radiosensitization in OCCC
Mediator Kinases and AML Cell Proliferation
Mengovirus Replicon for Enhanced Oncolytic Virotherapy
Mentored Patient Oriented Research in Lymphoma
Mentoring and Research in Cancer Stem Cells
Metabolic basis of B cell lineage leukemia relapse
Metabolic Imaging of Brain Tumor Response to Therapy
Methyltransferase Contributions to Genomic Stability and Cancer
Microfluidic assay to predict patient-specific multiple myeloma clinical response
MicroRNA and Transcription Factor Co-regulation in Cancer
MicroRNAs Modulate Therapy Resistance in Prostate Cancer
Modeling pediatric glioma in human ES cells:mechanistic and therapeutic insights
Modeling pediatric gliomas using a human pluripotent stem cell-based platform
Modeling the impact of mutations in ubiquitin ligase genes on transcriptional programs in endometrial cancer
Modifier of Cancer Sensitivity to Statins
Modulating signaling pathways in endothelial cells to abate leukemic progression.
Modulating systemic pro-oncogenic effects of focal image-guided tumor ablation
Modulation of Host Cell Exosome Content and Function by EBV LMP1
Molecular and cellular mechanisms of SCLC metastasis
Molecular Basis of KSHV oncogenesis
Molecular Characteristics of Treatment-resistant High-risk Neuroblastoma
Molecular Dissection of an Arntl2 induced pro-metastatic secretome
MOLECULAR GUIDED SURGERY FOR IMPROVED RESECTION OF GLIOBLASTOMA MULTIFORME
Molecular Interactions of APOBEC3 Enzymes with the Cancer Genome
Molecular Mechanisms of Tumor Behavior and Response to Therapy in HPV-positive Oropharyngeal Cancer
Molecular MR Imaging of the Desmoplastic Response in Pancreatic Cancer
Molecular Pathways of Interleukin-13 in Cutaneous T-cell Lymphoma
Monitoring tumor subclonal heterogeneity over time and space
Monocyte promotion of therapy resistance by immune and non-immune mechanisms
MRI-Guided Dendritic-Cell-Based Vaccine Immunotherapy for Pancreatic Cancer
Mucins and immune cell interactions in ovarian cancer pathogenesis & progression
Multifunctional, GBM-activatable nanocarriers for image-guided photochemotherapy
Multiplexed exosome analyses with DNA barcoding
Myc transcriptional regulation in T-ALL
Nanoconjugate delivery of proliferation and checkpoint inhibitors to treat glial tumors
Nanoparticle Delivery System for Ewing Sarcoma Treatment
Nanoparticle modified Human Fat Derived Mesenchymal Stem Cells for Brain Cancer
Nanoparticle-Based Triple Modality Imaging and Photothermal Therapy of Brain Tumors
Nanotechnology enabled targeting of p53 deficiency in human cancer
Near infrared intraoperative molecular imaging of lung adenocarcinoma
Neurotensin in Fibrolamellar Liver Cancer
New Frontiers in Pediatric Stem Cell Transplantation
New HuR inhibitor against pancreatic cancer EMT and CSCs
New Paradigms for Targeting Truncal Driver Mutations
New Ways of Targeting K-Ras
Notch signaling in small cell lung carcinoma
Novel Biomarkers to Risk-Stratify AML Patients with NPM1^Pos/FLT3-IT^Neg Genotype
Novel Bone-Targeting Combination Therapy for Osteosarcoma
Novel functions of D-type and E-type cyclins in normal and in cancer cells
Novel immunotherapy strategy for treatment of pancreatic cancer
Novel MAP Kinase Pathway Inhibitors to Treat Pancreatic Ductal AdenoCarcinoma
Novel Ras inhibitor prodrug for colorectal cancer
Novel RNA-Directed Therapy for the Treatment of Acute Myeloid Leukemia
Novel role of the polycomb repressive complex PRC2/EZH2 in glioblastoma
Novel Role(s) of Nrf2 in the Growth of Post-Transplantation Cancer
Novel Signaling Pathways Regulating Pancreatic Cancer Pathogenesis
Novel Strategies for Precision T-cell Therapies
Novel Strategies to Eliminate Resistance to B-cell Receptor Inhibitor Therapy in Lymphoid Malignancies
NSD1 Inactivation in Head and Neck Cancer
Oncogenic Disruption of the Circadian Metabolic Cycle in Cancer
Oncogenic programs driven by Notch signaling in B-cell lymphoma
Opening of the Blood-Brain Barrier to Antitumor Agents
Optimal DNA Brain-Penetrating Nanoparticle (DNA-BPN) Formulation for Glioblastoma (GBM) Treatment
Optimization of a clinical stage nanoparticle drug delivery platform
Optimizing Immunotherapy Strategies to Eliminate Recurrences after Cancer Surgery
Optimizing Ultrasound Enhanced Delivery of Therapeutics
Origins of BRAF-mutant hematologic malignancies and their therapeutic resistance
Overcoming IMiD resistance in Myeloma
Overcoming Primary Ibrutinib Resistance in Mantle Cell Lymphoma Using Patient-Derived Models and Molecular Profiling
p16 mechanisms in melanoma
Pancreatic Cyst Fluid miRNOME for Biomarkers of Pancreatic Cancer
Pancreatic Ductal Adenocarcinoma Targeted Ultrasound Contrast Agent Development
Pathogenic Mechanisms of CSF3R Mutations in Leukemia
Pathway Specific Combinational Therapy in Poor Prognosis B-Lineage Acute Lymphoblastic Leukemia
Pax2 loss in fallopian tube lesions and strategies for restoration in serous cancer
PCOS, Type II diabetes and ovarian cancer risk
Pediatric Hematology/Oncology Workforce Diversity and Healthcare Disparities
Peptide vaccine immunotherapy for children with recurrent low-grade astrocytomas
Peripherally-restricted cannabinoids for cancer and chemotherapy-induced pain
Personalized therapy for AML patients with a newly identified genetic alteration
Pharmacogenomic and circulating tumor cell approach to individualized treatment of pancreatic cancer
PHARMACOLOGICAL MODULATION OF POLY(ADP-RIBOSE) METABOLISM
Phase I Clinical trial with 4-Demethyl-4-cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) in Children with Cancer Involving the CNS
Phase II trial of mTORC1/mTORC2 inhibitor AZD2014 for sporadic meningioma
Photocleavage Technology for Improved Serum-based Multi-Biomarker Cancer Assays
PI3K Isoform Dependence in Adult Hematopoiesis and Myeloid Leukemia
Plasma Generation of Aqueous Chemotherapeutic Solutions
Plastic States Associated with Cellular Stress and Malignancy: Insights for Prevention and Treatment of Lethal Metaplastic Cancers
PNNL Proteome Characterization Center
PQ 5 Exploring whole mitochondrial genome of screen detected pre-neoplastic lung lesions by novel approaches
PQ1: Identification and characterization of genetic alterations for the progression of pre-neoplastic lung lesions by using novel PDx models and deep sequencing
Precision Quality Check of Immunotherapeutics via Single Cell Cytokine Mapping
Preclinical Models for Cancer Therapeutic Development
Preclinical Testing of a Novel Therapy Targeting AXL in Advanced Kidney Cancer
Predicting and profiling long-term survival after immune checkpoint inhibition
Prepare to Care, A Supported Self-Management Intervention for Head and Neck Cancer Caregivers
Prevention of Depression in Head and Neck Cancer
Prevention of radiation-induced neurocognitive dysfunction by induced adult neural stem cell
PRMT1-mediated metabolic reprogramming in leukemia progression
Probiotics for Prevention of Acute Graft-vs-Host Disease in Children with Cancer
Prognostic Biomarkers for ZIP4-mediated Cachexia in Pancreatic Cancer
Prospective immune profiling using methylation markers and pancreatic cancer risk
Proteasome inhibitor re-sensitizing molecules for treatment of refractory multiple myeloma
Proteo-genomic Discovery, Prioritization and Verification of Cancer Biomarkers
Proteome Characterization Center: A Genoproteomics Pipeline for Cance Research
Proton minibeams: Overcoming proton beams inability to spare superficial tissues
Provectors for treatment of ovarian cancer
Quantitative assessment of the role of collagen alterations in ovarian cancer
Quantitative Multimodal Image Guidance for Improved Liver Cancer Treatment
Rac1 GTPase in tumorigenesis and progression of pancreatic cancer
Radioiodinated Multifunctional PARP1 Imaging Probes for Diagnosis and Therapy
Radiotherapeutic Nanoseeds for Internal Radiation Therapy of Unresectable Solid Tumors
Real-time histopathology for intra-operative tumor margin delineation
Real-time monitoring of circulating pancreatic tumor cells and clusters
Receptor-Targeted Neuroendocrine Tumor Imaging with Generator-Produced Cu-62
Redefining Normal: personalized CA125 cutpoints for ovarian cancer screening
Regulation of Ceramide-Based Therapeutics in Acute Myeloid Leukemia
Regulation of multiple myeloma by S100A9 protein
Regulation of Nutrient Stress-Induced Macropinocytosis in Pancreatic Ductal Adenocarcinoma
Regulation of the Kidney Cancer Epigenome by Oncometabolite L-2-Hydroxyglutarate
Reolysin-based combination therapy in relapsed multiple myeloma
Repositioning Bazedoxifene as a novel IL-6/GP130 inhibitor for sarcoma therapy
Repurposing Anti-cancer Drugs to Prevent Growth of Osteosarcoma Metastases
Repurposing statins to enhance efficacy of BCL-2 antagonists in blood cancer
Revealing cancer metabolism via mass spectrometry and isotope tracers
Risk factors for molecular subtypes of NHL a prospective evaluation
Role of branched-chain amino catabolism in lymphopoiesis and lymphomagenesis
Role of DEAD-box helicase in microRNA biogenesis and Cancer
Role of EMSY protein complexes in the FA DNA repair pathway
Role of enhancer elements in regulating prometastatic transcriptional programs in osteosarcoma
Role of Follicular Dendritic Cells in B lymphoma
Role of Follicular Fluid Exosomes on Ovarian/Fallopian Carcinogenesis
Role of GAS41 in human cancer
Role of histone demethylated LSD1 as an epigenetic dependency in lymphoma
Role of Human Cerebrospinal Fluid Chemokines in the Invasiveness of Human Glioblastoma
Role of integrin VLA-6 in suppression of bone formation in myeloma
Role of Interleukin-22 and Innate Lymphoid Cells in Pancreas Cancer Initiation and Progression
Role of KLHL6 inactivation in mature B-cell malignancies
Role of Metabolic Adaptation in Isocitrate Dehydrogenase I Mutant Glioma
Role of Nix in pancreatic ductal adenocarcinoma
Role of SETBP1 in adult Ph+ acute lymphoblastic leukemia
Role of SLC13A3 in Renal Cell Carcinoma
Role of SNF5 in regulating SWI/SNF complex assembly & targeting in rhabdoid tumor
SCH: INT: Collaborative Research Intelligent Information Sharing: Advancing Teamwork in Complex Care
Screening for pancreatic cancer via nanocytology of duodenal cells
Sensitive Single Cell PhosphoCount Platform for Drug-Insensitive Cell Detection and Combination Drug Screening for Leukemia
Sensitizing Primary Bone Tumors to Radiation Therapy
SFK-inhibitor enhancement of ATRA-mediated differentiation of APL
Signaling cascades in cholangiocarcinoma development
Simultaneous Thermal and Osmotic Stresses in Tumor Ablation: Imaging and Biology
SIRT2 Inhibitors for the Treatment of B-cell Lymphoma
SIRT5 as a Therapeutic Target in Acute Myeloid Leukemia
Small molecule inhibitors targeting oncogenic drivers of hepatocellular carcinoma
Smartphone for molecular cancer diagnostic in Africa
Splicing factors and RNA processing alternations: exploring new players in glioblastoma development
Stem cell signals in pancreatic adenocarcinoma metastasis and therapy resistance
Structural basis of chemokine receptor signaling in tumor progression
Structural Variation in Neuroblastoma
Suppression of pancreatic tumorigenesis by the PTF1 transcription factor network
System analysis of p53 mutant associated cancer development with LFS patient- specific iPSCs
Systematic Light Exposure for Fatigue in Stem Cell Transplant Survivors
Systematic Programmed Illumination (sPI) of Hospital Rooms to Prevent/Reduce Cancer-Related Fatigue During Hematopoeitic Stem Cell Transplantation for Multiple Myeloma
Systemic Therapy with Infectivity-Selective Oncolytic Adenovirus for PDAC
Systems analysis of phenotypic switch in control of cancer invasion
Targeted Delivery of Brain Penetrating DNA Nanoparticles to Brain Tumors
Targeted Molecular Imaging of Cell Death in Ovarian Cancer
Targeted Nanotherapy for Pancreatic Cancer
Targeting B cell activating factor receptor (BAFF-R) as a novel therapeutic strategy for drug resistant Acute Lymphoblastic Leukemia (ALL)
Targeting Beta-Adrenergic Signaling to Control GVH and GVL Responses
Targeting BRD4 in Chronic Lymphocytic Leukemia (CLL) Disease Progression to Richters Transformation (RT)
Targeting cancer-associated cohesin alterations
Targeting CRLF2 and Ikaros Alterations to Reduce Health Disparities in Childhood Leukemia
Targeting CXCR5 for angioimmunoblastic T-cell lymphoma
Targeting cytokine mediated CREB activation in pancreatic cancer
Targeting cytokines to the tumor microenivronment using a high affinity single domain antibody to PD-L1
Targeting Determinants of OvCa Metastases in Engineered 3D Microfluidic Platforms
Targeting DYRK1A Modulation of GLI1 for Anti-Tumor Efficacy
Targeting extracellular matrix-cancer stem cell interactions in pancreatic cancer
Targeting high fat diet-driven DNA hypermethylation for AML chemoprevention
Targeting Human Cancers with Hemizygous Deletion of TP53
Targeting IKK and HDAC Mediated IL-8 Expression in Ovarian and Prostate Cancer
Targeting insulin receptor splicing for treatment of rhabdomyosarcoma
Targeting macrophages for immunotherapy in pancreatic cancer
Targeting Multiple Myeloma with Smac-mimetics and HDAC Inhibitors
Targeting Neuroblastoma with armed T cells
Targeting nutrient-sensing pathways in cancer
Targeting PARP and RAD52 to induce dual synthetic lethality in leukemia patients identified by gene expression and mutation profiling
Targeting PRL2 phosphatase in acute myeloid leukemia
Targeting protein-protein interactions of Bmi1 oncoprotein
Targeting TCA cycle in Brain Tumor Initiating Cells
Targeting the APC/Cdc20 E3 ubiquitin ligase for chemoradiation sensitization
Targeting the Ig-light chains with CAR-T cells in lymphoid tumors
Targeting the MLL complex in Castration Resistant Prostate Cancer
Targeting vismodegib-resistant tumors using BH3 mimetics
Temozolomide Perillyl Alcohol Conjugate as Treatment for Recurrent Malignant Brain tumors
Testicular effects of modern chemotherapy regimens in osteosarcoma survivors
TET enzymes as guardians of genome stability
The 19th International Workshop on KSHV and Related Agents
The CARMA3/Bcl10/MALT1 signalosome in osteosarcoma metastasis
The cyclic AMP/phosphodiesterase4 axis regulates proximal B cell receptor signaling and offers a new therapeutic strategy for B cell lymphomas
The EDRN Mesothelioma Biomarker Discovery Laboratory
The effect of statins on B cell dysfunction in HIV infection
The Hippo/YAP Signaling Pathway in Ovarian High Grade Serous Carcinoma
The histone demethylase KDM3A upregulates MCAM to promote Ewing Sarcoma metastasis
The impact of aging-associated chronic inflammation on the selection for oncogenic driver mutations in hematopoietic stem cells
The Paradoxical Role of mTORC1 in the Growth of Nutrient-deprived Pancreatic Cancer Cells Harboring Ras Mutations
The role of AXL-ABL axis in Barretts carcinogenesis
The Role of EglN1 and HIF in Normal Hematopoiesis and in Leukemia
The role of glioblastoma derived activated leukocyte cell adhesion molecule in peripheral monocyte PD-L1 induction and immunosuppression
The role of IL-27 cytokine in hepatocellular carcinoma (HCC) development
The role of KIF2C/AURKA signaling in cilia loss and progression of glioblastoma.
The role of Lin28/let 7 pathway in Wilms tumor
The Role of LIN28B Signaling in Mediating the Oncogenic Phenotype in Neuroblastoma
The Role of LMO2 in the Pathogenesis of T-cell Leukemia
The Role of lncRNA MEG3 in Clinically Non-functioning Pituitary Adenomas
The Role of MMSET in the Pathogenesis and Progression of Lymphoid Malignancy
The role of Neuropilin 1 in Glioma Associated Microglia and Macrophages
The role of optical biomarkers in endoscopic detection and therapeutic monitoring of gastrointestinal cancer
The role of PRAME in promoting metastasis in uveal melanoma
The role of Prrx1 in acinar-ductal metaplasia during pancreatic tumorigenesis
The role of Sin3B in normal and malignant hematopoietic stem cell functions
The Role of Suppressor of Fused in Neural Stem Cells and its Implications in Tumorigenesis
Therapeutic approaches for LKB1-deficient non-small cell lung cancer
Therapeutic insights through patient derived leukemia xenografts
Therapeutic strategies for targeting PARP1 in small cell lung cancer
Therapeutic targeting of glutamine metabolism in MDS
Therapeutic targeting of Kras-driven Lung Adenocarcinoma
Therapeutically Targeting Plasmacytoid Dendritic Cells in Multiple Myeloma
Three-dimensional, mechanically tunable scaffold systems to model osteosarcoma heterogeneity and therapeutic response
Toward identification of a family of novel NF-kB inducers
Towards the automation of MR spectroscopic imaging in patients with glioblashoma
Transcriptional CDKs as therapeutic targets in MYC-dependent cancers
Transcriptional Control of Leukemic Evolution in Primary Myelofibrosis
Transcriptomic profiling and functional characterization of fusion genes in recurrent ovarian cancer
Transforming the diagnosis and care of patients with CTCL using TCR sequencing
Transporters and hematopoietic toxicity
Treatment of glioma with nanocombretastatin with MRI monitoring
TSPO Ligands for Cancer Imaging
TSPO-PET to Image Pancreatic Cancer and High-Risk Precursor Lesions
Tumor Genetics and Response to Checkpoint Blockade in Melanoma and Ovarian Cancer
Tumor subtypes and therapy response in pancreatic cancer
Tumor-associated Physiological Changes Arising from Ras-induced Mitochondrial Fission
Tumor-intrinsic oncogenic alterations and evasion of anti-tumor immunity
Tumor-Targeted Chemo-Immunotherapy for Osteosarcoma Metastasis
Ultrasensitive SERS Nano-Sensors for Pancreatic Cancer Diagnosis and Prognosis
Understanding cell intrinsic and context dependent metabolic adaptations of cancer cell
Understanding Esophageal Adenocarcinoma Progression Using Inflammatory and Neoplastic Extracellular Matrix Hydrogels
Understanding Psychosocial and Immunologic Responses in Indolent Lymphoproliferative Disorders
Understanding the mechanism of H3K9 HMT mediated suppression of melanoma
Unlocking the Therapeutic Potential of Retinoic Acid in Acute Myeloid Leukemia
Unlocking Tumor Immunophenotype in Responders versus Non-Responders in Metastatic Uveal Melanoma Patients Receiving Immune Checkpoint Blockade
Unraveling the Function of RNA-Binding proteins in B-lympoblastic Leukemia
Urine DNA Kit for monitoring HCC recurrence
Using CRISPR/Cas9 to dissect the role of FUS-CHOP in tumor response to radiation therapy
Using markers to improve pancreatic cancer screening and surveillance
Using the Collaborative Cross for Model Studies of Intestinal Cancer
Using zebrafish to study the role of six1a/b and microRNA-30a in rhabdomyosarcoma (RMS) initiation and progression
Validating Rapid Microfluidic Isolation of Personalized Aptamers for Monitoring Minimal Residual Disease in Multiple Myeloma
Validation and Clinical Relevance of Ovarian Cancer Molecular Subtypes
Validation of biomarkers for early diagnosis and risk prediction of pancreatic neoplasms
Validation of FOXM1 as a new therapeutic target in high-risk myeloma
Validation of Methylated Vimentin as a Diagnostic Test for Barretts Esophagus
Video Informed Consent Tools to Improve Care for Patients With Advanced Pancreatic Cancer
WDR5 as a Critical Co-Factor for MYC
Weakened spindle checkpoint in vivo: a cause of aneuploidy and cancer in FA?
Web-based Physical Activity Intervention for Children with ALL
Yap and beta-catenin interactions in liver: Implications in Pathophysiology
2015
(PQ4A) Metabolic Plasticity of Pre-Malignant Cells During Tumor Progression
(PQA3) Why is Ovarian Cancer Primarily a Disease of Postmenopausal Women
(PQB4) Stochastic Profiling of Functional Single-Cell States Within Solid Tumors
(PQC2) Localization as a determinant of cancer dormancy
(PQC2) Niche-responsive RNA editing by ADAR1 in dormant multiple myeloma initiating cell maintenance
(PQC3) Immunological Basis of Health Disparities in Multiple Myeloma
18th International Workshop on Kaposis sarcoma herpesvirus and related agents
2015 Hormone-Dependent Cancers Gordon Research Conference and Gordon Research Seminar
4C and Genome Editing for Causal SNP and Gene Discovery at Cancer Risk Loci
4th International RASopathies Symposium
5-hydroxymethylcytosine in HPV(+) and HPV(-) oral and oropharyngeal cancers
A biochemical companion diagnostic platform to measure kinase inhibitor pharmacodynamics in leukemia
A cancer-targeted phospholipid ether analog for molecular radiotherapy of pediatric solid tumors
A cell-based liquid biopsy approach for early pancreatic cancer detection
A Clinical Center to Study Immunological and Hormonal Biomarkers for the Diagnosis, Prediction and Treatment of Chronic Pancreatitis and its associated development to Diabetes and Pancreas Cancer
A Creative Integration of Omega-3 Fatty Acids into Pancreatic Cancer Chemotherapy
A differentiation-based mechanism limiting pancreatic tumor initiation
A Label-Free, Point-of-Care Platform to Diagnose Acute Promyelocytic Leukemia
A Mechanistic Understanding of Neuronal Activity Promotion of High-Grade Glioma Growth through Activity-Regulated Secretion of Neuroligin-3
A Nanotechnology Platform for Suicide Gene Therapy of Recurring Ovarian Cancer
A new energy restriction mimetic that targets pancreatic cancer
A New Lab Based Algorithm for HCC Surveillance in Patients with Cirrhosis
A novel combination approach for pancreatic cancer prevention
A Novel Mechanism for Drugs Targeting the CRM1 Nuclear Export Protein in Leukemia
A novel miR-198 replacement therapy for pancreatic cancer
A novel mouse model to identify biomarkers of IPMN formation and progression
A novel strategy to overcome resistance in Temozolomide-Refractory Glioblastomas
A Phase I Study of Intracranially Administered Carboxylesterase-Expressing Neural Stem Cells in Combination with Intravenous Irinotecan in Patients with Recurrent High Grade Gliomas
A Phase I/II Clinical Trial to Investigate Fucosylated Tregs in Prevention of GVHD
A Phase IIa Study of rHuIL-12 as an Immunotherapy and Radiomitigator for CTCL Patients Receiving Radiotherapy
A Post-Visit Patient Portal Tool to Promote Colorectal Cancer Screening
A Prospective Investigation of the Oral Microbiome and Pancreatic Cancer
A role for macrophage phenotype in regulating metastasis in pancreatic carcinoma
A scalable platform for target validation in GEMM models of gastrointestinal malignancies.
Aberrant activation of HGF/MET signaling as a therapeutic target in AML
Adding patient and provider viewpoints to rectal cancer practice variation data
Addressing Tobacco Use Disparities through an Innovative Mobile Phone Intervention: The textto4gosmokelesstobacco
Advanced development and validation of targeted molecular counting methods for precise and ultrasensitive quantitation of low prevalence somatic mutations
ALTERED MICROBIOME IN PANCREATITIS, DIABETES AND PANCREATIC CANCER
Alternatively Spliced Tissue Factor and Pathobiology of Pancreatic Cancer
Analysis of Racial Disparities in HCC by Systems Metabolomics
Apoptotic Proteins as Molecular Modulators of Stem Cell Fate
Aptamers as Proteomic Tools for Pancreatic Cancer Biomarker Identification
Arf6 inhibitors for the treatment of uveal melanoma
Ashwagandha supplementation enhances ovarian tumoricidal activity of NK cells
ATR: a novel therapeutic target for medulloblastoma identified by its role in cerebellar development
Autophagy, mTOR inhibitors and phenformin in hepatocellular carcinoma
Beneficial effects of Honokiol against liver cancer
Biologic Markers of Chronic Graft vs. Host Disease Therapeutic Response
Biomarkers in pediatric versus adult myelodysplastic syndromes
Biomarkers of human papillomavirus (HPV) infection and risk of two increasing cancers
Biophotonics to Couple Pancreatic with Upper GI Screening via Ultrathin Endoscopy
BMP4 Engineered Mesenchymal Stem Cell Therapy for Glioblastoma
BMX-001 as a Therapeutic Agent for Treatment of High-Grade Gliomas
Breaking immune tolerance to Survivin in Multiple Myeloma
Cancer Gene Discovery to Identify Targetable Targets
Cancer imaging phenomics software suite: application to brain and breast cancer
Cancer Initiating Cells and Treatment Resistance
Cancer Risks in Shipyard Workers Exposed to Asbestos and Welding Fumes
Career Development and Increasing Diversity in Pediatric Hematology/Oncology
Cdk5 signaling in ICN1-induced T Cell Leukemogenesis
Cell-free tumor DNA in cerebral spinal fluid decodes tumors of the central nervous system
Cellular, molecular and quantitative imaging analysis of screening-detected lung adenocarcinoma
Characterization of breast cancer dormancy in bone
Characterization of GATOR1 signaling to mTORC1 and its role in cancer
Characterization of mTOR signaling during early stages of gliomagenesis
Characterization of replication-mediated DNA damage in B lymphocytes
Characterization of the LGL Leukemia Virus (PQ 12)
CHARACTERIZATION OF THE MOLECULAR INTERPLAY BETWEEN HOXA9 AND OGT IN ACUTE LEUKEMIA
Characterization of virus-specific CD8 T cell responses in Merkel Cell Carcinoma
Characterizing functional targets of a non-coding RNA oncogene, SNORA42
Characterizing MSI2 in leukemia
CHEMOPROTEOMICS PROFILING OF PARTHENOLIDE IN HUMAN GLIOBLASTOMA
Chemosensitizing Hypoxic Multiple Myeloma With Tunable, Long-Lived Oxygen Carriers
Childhood Leukemia International Consortium Scientific Annual Meetings
Chimeric Antigen Receptor T cell Therapy for Acute Myeloid Leukemia (AML)
Chronic Pancreatitis, Diabetes and Pancreatic Cancer: A Prospective Approach
Clinical efficacy of the antitumor agent ONC201 in GBM
Clinical Investigation of the Ceramide NanoLiposome for Advanced Solid Tumors
Clinical Significance of Pancreatic Cancer Differentiation and Dedifferentiation
Clinical Trial of ABC294640 in Patients with Refractory Multiple Myeloma
Clinicopathological significance of PDLIM2 in HIV/AIDS-related malignancies caused by KSHV
Cloud quantitative imaging for whole-body tumor burden in neurofibromatoses
COG Biospecimen Bank
Combating Resistance to Antiangiogenic Therapy in Renal Cell Carcinoma
Combination Immunotherapy of a Novel Superagonist IL-15 Complex and Anti-CD20 Antibody for Indolent Non-Hodgkin Lymphoma
Compact Representations of Dynamic Liver MRI
Consequence of collective cell invasion in glioblastoma
Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer: Coordinating and Data Management Center (CSCPDPC-CDMC)
Consortium for the Study of Pancreatitis: Pittsburgh Clinical Center
Control of GVHD and Leukemia Relapse by Targeting Cell Metabolism
Controlling Esophageal Cancer: A Collaborative Modeling Approach
Convertible MRI contrast signaling delivery and release of anti-glioma nano-drug
CRM1 INHIBITORS SENSITIZE MULTIPLE MYELOMA CELLS TO TOPOISOMERASE II AND PROTEASOME INHIBITORS
Crosstalk Between Platelets and Brain Tumor Initiating Cells in Glioblastoma
CSF2 receptor mediated actions in t(8;21) leukemia
Cytokine- and Satellite Cell-mediated Muscle Disease Promotion
Cytoplasmic FOXM1 contributes to the higher complete remission and longer overall survival of AML patients after chemotherapy
Deciphering Links Between Inflammation and Cancer with IMP-1 Inhibitors
Deciphering SIRT6-dependent metabolic liabilities in Pancreatic cancer
Decoding and targeting the PI3K-mTOR signaling network in cancer
Defining the Functional Role of Mutations in Diffuse Large B cell Lymphoma
Defining the functions of extracellular shed vesicles in cancer progression
Defining the Role for A Lipid Kinase in the Progression of Pancreatic Cancer
Defining the role of ERK1 and ERK2 in Pancreatic Cancer
Defining the role of mutant XPO1 in chronic lymphocytic leukemia
Defining the role of RBM10 in RNA processing and tumor suppression
Detection of 5-hmC as a Novel Screening Biomarker for Pancreatic Cancer
Detection of major HBV integration sites in urine as a biomarker for HBV-associated liver cancer
Determining the mutational landscape of circulating multiple myeloma cells
Developing a Screen for Novel Therapies with Reprogrammed Pancreatic Cancer Cells
Development and Optimization of an Analytical Chemical Separations Technique to Analyze E3 Ligase Activity in Single Cells
Development of a comprehensive research program in mantle cell lymphoma in the ibrutinib era
Development of a Minimally Invasive Surgical Device for the Treatment of Esophageal Cancer
Development of a Novel Inducer for EBV Lytic Therapy
Development of a Web-Based Group Intervention to Support Ovarian Cancer Survivors
Development of an ADC against Pancreatic Cancer
Development of mosaic mouse models of HCC for genetic interspecies inference
Development of novel lung cancer therapeutics targeting the DNA damage response
Development of novel targeted agents in pancreatic cancer
Development of Nuclear Auger Emitters for Targeted Radiotherapy
Development of Trabectedin Analogs that Target the EWS-FLI1 Transcription Factor
Diet patterns, aspirin use, obesity and multiple myeloma: a prospective analysis
Differential MRI imaging for brain tumor metastases diagnosis and treatment monitoring
Differential Regulation of PI3KC2beta by Ras Protooncogenes In Acute Myeloid Leukemia
Direct coregulation of Notch1 by Zmiz1 in T-cell leukemia
Discovery and Development of a Selective pan-FLT3-ITD Kinase Inhibitor Clinical Candidate for the Treatment of FLT3-ITD-Driven AML
Discovery and targeting of apoptosis resistance mechanisms in high-risk T-ALL
Discovery of Novel Rare Variants as Ovarian Cancer Susceptibility Factors
Discovery of Synthetic Lethals in Pan-Cancer Genomic Data Using Boolean Methods
Disruption of circadian rhythm in hypoxia
Disruption of the Host DNA Damage Response by Hepatitis C Virus
Dissecting ALK4 Function in Cancer Progression
Dissecting CRBN-substrate interactions in the mechanism of lenalidomide
Dissecting Genetic and Epigenetic variation in the Cancer Regulome
Dissecting Pediatric Brain Tumor Microenvironment to Improve Treatment
Dissection of Pten-regulated signals in hepatopathogenesis
Distribution, regulation and function of a novel lysine PTM in metabolic disease
Do cardiovascular risk factors modify the cardiotoxicity of lymphoma treatments?
Does Screening for HCC in Cirrhotic Patients Reduce HCC-related Mortality?
Dosage-Dependent Hedgehog Signaling in Pancreatic Cancer
Drivers and dependencies as therapeutic targets in KRAS-mutant lung cancers
Dual recombinase models of pancreatic cancer
Dual targeting of XPO1 and BTK in B cell malignancies
Dynamic Complexity of Brain Tumor Stem Cells
DYRK1A signaling in control of cell growth, proliferation and DNA damage repair
Early Phase Clinical Trials in Imaging and Image-Guided Interventions
ECM geometrical and mechanical properties modulate RTK signaling
ECOG-ACRIN Biorepositories to Support NCTN
Effector T Cell Trafficking in Ovarian Cancer
Efficacy of Dendritic Cell Vaccines Targeting CMV in Glioblastoma (phase 2 DC vaccine)
Efficacy of PDI inhibitors in glioblastoma
Elucidating and targeting the molecular foundations of IDH mutant glioma
Elucidating Mechanisms of Resistance to Src Inhibition in Thyroid Cancer
Elucidating the role of microRNAs in the initiation of multiple myeloma
Elucidation of the impact of commonly co-altered genes on chemosensitivity using a novel model of high-grade serous ovarian cancer
Employing mouse models to translate early detection of pancreas cancer
Endoenteric Balloon Coils for Improved MR Imaging of the Pancreas and Upper GI Tract
Endoplasmic reticulum stress and oncoviral therapy
Endovascular Chemofiltration: Optimizing Removal of Chemotherapeutics and Nanoparticles from the Blood to Reduce Toxicity
Engineering therapeutic and diagnostic proteins for tumor biomarker mesothelin
Enhancing Antibody-directed Innate Immunity to Improve Cancer Outcome
Enhancing Liver Cancer Treatment With Image-Guided Magnetic Hyperthermia
Epidemiology of Ovarian Cancer in African-American Women
Epigenetic Gene Regulation by JAK1 Kinase in Diffuse Large B-Cell Lymphoma
Epigenetic mechanisms of drug resistance in T-cell acute lymphoblastic leukemia
Epigenetic Regulation of Neuroblast Differentiation
Epithelial-stromal cross-talk in esophageal inflammation and carcinogenesis.
Esophageal cancer in West Kenya
Examining the Role of Rho Kinase in the Pathogenesis of ABC-DLBCL
Exosome-Dependent Trafficking of Epstein-Barr Virus LMP1
Exploitation of RAS signaling to develop therapy and early detection strategies for PDA
Exploiting Notch inhibition as a mechanism to overcome resistance in ccRCC
Exploring a new therapeutic approach through targeting epigenetic enzymes in ALL
Exploring the oncogenic potential of human APOBEC3 cytosine deaminases
Fas protects cancer stem cells from death
FASEB SRC on Helicases and Nucleic-Acid Based Machines: From Mechanism to Insights into Disease
FAST TRACK: IND Enabling Studies for Oral Cancer
Feasibility of Molecular Cytology for the Management of Barretts Esophagus
FFPE Validation of a Survival Gene Signature in HPV-Negative Oral Cavity Cancer
Finding Novel Pancreatic Cancer Oncogenes Using an Innovative 3D Culture System
Functional dissection of oncogenic enhancers
Functional imaging-directed adaptive therapy of head and neck cancer
Functional Inhibition of Deubiquitylase HAUSP to Disrupt Glioblastoma Stem Cells
Function-blocking anti-ADAM protease antibodies for inhibition of tumorigenesis
Gene-engineered adoptive T cell immunotherapy of GBM
Generation and characterization of adduct-specific anti cisplatin DNA antibodies
Generation of NKT cells from adult stem cells for adoptive immunotherapy
Genetic analysis of ras mutation specificity in skin and lung cancer
Genetic and Environmental Risk of Liver Disease/Cancer among Mexicans
Genetic evolution of glioblastomas during radiation and temozolomide therapy
Genetic Framework and Molecular Mechanism of Fanconi Anemia
Genetic Predictors of Response to mTOR inhibitors in advanced Renal Cancer
Genetic susceptibility to acute lymphocytic and myeloid leukemia
Genetic Susceptibility to Pediatric Glioma inIndividuals and Diverse populations
Genome maintenance by Hdacs1,2 and their inhibition for Pre-B leukemia therapy
Genome-Wide Association Study (GWAS) in Hepatocellular Carcinoma (HCC)
GENOMIC ANALYSIS OF INHERITED BREAST AND OVARIAN CANCER
Genomic and transcriptomic characterization of atypical carcinoids of the lung
Genomic studies for understanding etiology of esophageal adenocarcinoma
Germline BAP1 Mutations and Malignant Mesothelioma: Mechanisms and Early Detection
Glutamine catabolism in c-Myc driven liver tumor development
Glycan control of stem cell-associated pathways in pancreatic cancer
gp130 as a novel therapeutic target in ovarian cancer
Gut microbiota mediated bile acid alterations in hepatic carcinogenesis
Harnessing Csf-2 compartmentalized role on tissue resident phagocytes to uncouple anti-tumoral from pathological immunity induced by checkpoint inhibitors
HAUSP inhibitors in p53-wild type and p53-mutant tumors
Heme oxygenase-1 as a tumor factor and therapeutic target for Kaposi sarcoma
Hepatic Stellate Cells and Liver Cancer
HHV-8 vIRF interactions in the context of infection
High fat diet stimulates pancreatic cancer through the actions of Cholecystokinin
High Specificity MicroRNA Microarray Analysis without PCR for Cancer Screening and Research
High-throughput immunoglobulin gene sequencing as a peripheral blood minimal residual disease assay to predict post-transplant relapse risk in multiple myeloma
HIV-1 Vif in AIDS-Related Malignancies
How do genome alterations cause human lung cancer?
How Does FLT3 Mutation Regulate Myeloid Differentiation in Acute Myeloid Leukemia
HTS for Identification of Novel Inhibitors of Pyk2 Activity
iDDS probes detecting IDH mutants in brain cancer
Identification and development of inhibitors of the Hippo-Yap pathway
Identification and Targeting Therapy Resistant Osteosarcoma
Identification and validation of synthetic lethality in KRAS mutant lung adenocarcinoma patient derived xenografts
Identification of Cell Surface Markers for Risk Stratification of Barretts Esophagus Patients
Identification of Loci Modifying Atm Lymphomagenesis
Identification of Small Molecule Inhibitors of PHF5A for Glioblastoma
Identification of synthetic lethal interactors in pancreatic cancer
Identifying BRCA1 protein variants that provide resistance to therapy
Identifying Early Failure to Anti-angiogenic Therapy in Recurrent GBM
Identifying microRNA Targets for Early Detection of Myeloproliferative Neoplasms
Identifying vulnerabilities and therapeutic targets in Glioma Stem Cells
IDO2 Targeting in Pancreatic Cancer
IGF-II-Based Approach to Therapy for Pancreatic Cancer
Illuminating molecular targetable pathways in HNSCC
Imaging and Molecular Correlates of Progression in Cystic Neoplasms of the Pancreas
Immunotherapeutic Nanoparticle Delivery to Melanoma With MR-Guided Focused Ultrasound
Immunotherapeutic targeting of the Glioblastoma Mutanome
Improving BTK Directed Therapy for CLL
Improving radiation response by targeting O2 metabolism via the PI3K/mTOR pathway
Improving Radiation Therapy For Pancreatic Cancer
Improving risk allocation and developing novel therapies for children with T-ALL
In Vivo Drug Testing of Pediatric CNS Tumors Using Patient Derived Orthotopic Xenograft Models
Indiana University (IU) Clinical Center for Chronic Pancreatitis Clinical Research Network
Inhibiting MYC for the Treatment of Multiple Myeloma
Injectable Implants for Increased Tumor Treatment Volume Using Pressure Driven Diffusion
Innovative solutions to spatial uncertainty in geocoding
Integrated models for metastatic phenotype and outcome prediction in osteosarcoma
Integrated Systems for the Analysis of Circulating Multiple Myeloma Cells (CMMCs)
Integrative Analyses to Identify Pancreatic Cancer Susceptibility Genes
Integrative approaches to elucidate p53 transcriptional networks during carcinogenesis
Internet-Assisted Cognitive Behavior Intervention for Targeted Therapy Fatigue
Interrogation of MLL2 as a tumor suppressor gene in lung cancer
Intratumoral Heterogeneity and Tumor Evolution in Lymphoma
Investigating a Novel Glutamine Metabolism Pathway in Pancreatic Cancer
Investigating non-coding mechanisms of functional dysregulation in neuroblastoma
Investigating the cytomegalovirus link to glioblastoma using a novel mouse model
Investigating the role of the small GTPase RIT1 in lung adenocarcinoma
K-Ras mutant-specific vulnerabilities for novel pancreatic cancer therapies
KS-Detect: A solar-powered and smartphone integrated instrument for point-of-care diagnosis of Kaposis sarcoma
Large Volume Intratumoral Injection Device for Therapeutic Liver Infusions
Lassa-VSV targets and kills glioma, and is not neurotoxic
Leukemia-promoting effects of microbiota
Leveraging Genetically-Engineered Mice to Optimize Pediatric Glioma Management
Leveraging GxE interaction to understand pancreatic cancer and altered metabolism
Leveraging in vivo models to identify epigenetic vulnerabilities in leukemia
Ligase III regulates survival from crisis induced by gradual telomere shortening
Liposomal Doxorubicin and Pluronic Combination for Cancer Therapy
Liver Cancer Risk with rAAV Gene Therapy
Long non-coding RNAs in hematopoiesis and blood malignancy
Loss of Fractalkine Signaling Affects CNS Tumor Growth via Microglia Interactions
Lymphoma monocyte crosstalk: mechanisms of chemo-immunotherapy resistance
Magnetic Micelles for Catheter-Directed Sorafenib Delivery to Liver Tumors
Markers of Cognitive Decline During Treatment for Childhood ALL
Mass Spectrometry Imaging for Clinical Diagnosis and Prognosis of Human Cancers
Maximal MYC control using dual PI-3K/BRD4 (kinase/epigenetic) inhibitors
MDSCs in Ovarian Cancer
Mechanism of tumor promotion by the H3K9 histone demethylase KDM3A in Ewing Sarcoma.
Mechanisms and Function of Suppressed RAG Expression by DNA Double Strand Breaks
Mechanisms for sensitivity to PARP inhibitors in cancers involving ALT NHEJ
Mechanisms of obesity-induced hepatocarcinogenesis
Mechanisms of PARP Inhibitor Resistance in Ovarian Cancer
Mechanisms of regulation by RNA in acute myeloid leukemia
Mechanisms of resistance to ALK inhibitors in ALK-rearranged lymphoma
Mechanisms of Tumorigenic Transformation of Barretts Esophagus
Mechanisms underlying cytokine-induced memory-like natural killer cell differentiation and maintenance.
Mechanistic and Informatics Based Analysis of STAT1 Actions in Pancreatic Cancer
Merkel cell polyomavirus infection, DNA damage response and cancer
Merkel cell polyomavirus T antigens in tumorigenesis
METABOLIC DRIVERS OF LUNG CANCER INITIATION, PROGRESSION AND THERAPY RESPONSE
Metabolic pathways in leukemia
Metabolic Regulation in Leukemia-Initatiating Cells
Method to analyze X-chromosomal genetic data
Methylation and mutations in RB1 and variants of synthetic folic acid metabolism
Microenvironmental Regulation of Glioblastoma Angiogenesis via CHD7
MicroRNAs mediating Notch signaling in lung adenocarcinoma
Misassembled BAF complexes in human cancer: structural and functional consequences
Mitochondrially Targeted p53 DBD for Treatment of Ovarian Cancer
Modeling Neoplastic Progression in Barretts Esophagus
Modeling the Molecular Determinants of Induced Anti-Tumor Immune Responses in Mantle Cell Lymphoma
Modified MIS Production & Process Development for Preclinical & Clinical Studies
Modulation of cancer specific transcriptional factors with small molecules
Modulation of MicroRNAs with Xenobiotics to Target c-Myc
Modulation of the Immune System as a Strategy to Treat EGFR Mutant Lung Adenocarcinoma
Molecular and Therapeutic Basis of Morphometric Aberrations in Brain Tumors
Molecular determinants of PARP inhibitor sensitivity in 11q-deleted malignancy
Molecular mechanisms of focal adhesion kinase in promoting hepatocarcinogenesis
Molecular Mechanisms of G5-7 Allosteric Inhibition of Jak2
Molecular mechanisms of myeloid suppressor genes on chromosome 5
Molecular MR Imaging of the Desmoplastic Response in Pancreatic Cancer
Molecular Pathogenesis of Acute Myeloid Leukemia
Molecular understanding of cytokine-Ras signals in leukemic bone marrow
Monitoring disease progression in follicular lymphoma with next-gen sequencing
Motion Management of Pancreatic Cancer in MRI-Guided Radiotherapy
MR-HIFU induced drug delivery for pancreatic cancer treatment
MRI-Guided Irreversible Electroporation Ablation for Liver Tumors
MRI-Monitored Delivery of Sorafenib-Eluting Microspheres to Liver Tumors
Multifunctional Hollow Gold Nanospheres for Concurrent Photothermal-Chemotherapy
Multifunctional polymeric carriers for the intracellular delivery of protein cancer therapeutics
Multiplexed imaging of biliary intra-epithelial neoplasia
Multiplexed Multi-Modal Endoscopic Imaging of Cancer Biomarkers
Multi-Tensor Decompositions for Personalized Cancer Diagnostics and Prognostics
Murine Models on SALL4 in Hepatocellular Carcinoma
Musashi-mediated control of pancreatic cancer growth and progression
Mutation Profile as Translatable Prognostic Biomarker of Uveal Melanoma
Mutations in Runx1 and epigenetic modifiers cooperate in leukemogenesis
MYC as a Biomarker in Aggressive Non-Hodgkin Lymphoma
MYC is a critical downstream effector in KRAS-driven pancreatic cancer
MYC-dependent loss of splicing fidelity in Glioblastoma multiforme
Myc-induced pathways in B cell lymphoma initiation and survival
Myelodysplastic Syndrome Target Identification and Validation
Nano-cocktail overcomes multidrug-resistance for ovarian cancer therapy
Nanoparticles for selective and combinatorial delivery of siRNA to brain cancer
Nanoplasmonics-based molecular analysis tool for molecular biomarkers of cancer
Nanoprobe-enabled Delineation of Tumor Margins for Improved Surgical Therapy
Nanoscale Metal-organic Frameworks for Light Triggered and X-ray Induced Photodynamic Therapy of Head and Neck Cancers
Neuroimmune Mechanisms of Cancer-Related Symptoms in Oral Squamous Cell Carcinoma
Neuropeptide Y (NPY) as a hypoxia-driven metastatic factor
New Therapeutic Targets in AML
New transgenic animal model to study pancreatic cancer
NKT cells with chimeric antigen receptors
Non-invasive Differentiation of Benign Lesions from Aggressive Pancreatic Cancer
Novel AHCT Regimen for Advanced Hodgkin Lymphoma using Y-90 anti-CD25 with BEAM
Novel BPTES Analogs for the Treatment of Pancreatic Cancer
Novel immunological biomarkers ovarian cancer prognosis
Novel Inhibitors of Multi-Drug-Resistant Mutants of BCR-ABL for the Treatment of Chronic Myelogenous Leukemia (CML) and Ph Positive Acute Lymphocytic Leukemia (ALL).
Novel nano-plasmonic technology for quantitative analysis of cancer exosomes
Novel role of compensatory proliferation in human brain tumor
Novel Strategies to Potentiate a Ras-targeted Oncolytic Herpes Simplex Virus
Novel Strategies to Target Leukemia-Stromal Interactions
Novel targeted therapies for isocitrate dehydrogenase mutant cholangiocarcinoma
Novel Targeted Therapy for AML
Novel therapeutic approach in treatment of glioblastoma using sustained delivery of Connxin43 carboxy-terminal peptide encapsulated in biodegradable nanoparticles in combination with temozolomide
Novel therapeutics of targeting mTOR pathway in T-cell leukemia
NOVEL ULTRASENSITIVE CANCER BIOMARKER ASSAY PLATFORM UTILIZING PALLADIUM CATALYZED HIGH-GAIN CHEMICAL AMPLIFICATION
Nucleotide Metabolism in Senescence and Platinum Resistance of Ovarian Cancer
Nutritional Control of Cancer Cell Function by Amino Acids
Occupational Pesticide Use and Risk of Lymphoid Cancers
Oncogenic Function of Ca2+ Channel Orai1 in Esophageal Carcinogenesis
Oncolytic Herpes Simplex Virus Interactions with Glioblastoma Stem Cells
Oncolytic Polovirus, Immunotoxin, and Checkpoint Inhibitor Therapy of Gliomas
Oncolytic virotherapy and immunotherapy in the treatment of brain tumors
Online monitoring and image-guided treatment of chemoresistant micrometastases
Open source diffusion MRI technology for brain cancer research
Optimization and Efficacy of Covalent Ire-1 RNase Inhibitors in CLL
Optimization of a clinical stage nanoparticle drug delivery platform
Optimization of radiofrequency ablation with electrically conductive particles
Optimizing demethylating therapy for IDH1 Mutant Malignant Gliomas
Origin and Lineage of Differentiation of Kaposis Sarcoma
Tumor Embolization Using A Novel Catheter With Integrated Flow Regulation
Tumor priming sequences combined with novel nanoparticle drug carriers for enhanced therapeutic efficacy in pancreatic cancer: a tripartite USA/Northern Ireland/Republic of Ireland consortium
Tumor Suppressor Localization and Function at the Peroxisome
Tunable Microchip Sorting of BRCA1 Nuclear Assemblies
Two phospho-compounds for pancreatic cancer prevention
U01-Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer Clinical Centers
Ubiquilin1 regulates EMT and metastasis of human lung adenocarcinoma
UCLA Multifunctional Mesoporous Silica Nanoparticle Platform for Treatment of Pancreas Cancer
Underlying Mechanisms in Angiosarcoma
Understanding and Targeting Chemotherapy Resistance in Acute Myeloid Leukemia
Understanding EGF receptor activation by growth factors and oncogenic mutations
Using Adductomics to Characterize Exposures to Carcinogens
Validating a mouse model of ovarian cancer for early detection through imaging
Validating the eCyPA/CD147 signaling complex for myeloma therapy
Validation and Clinical Relevance of Ovarian Cancer Molecular Subtypes
Validation of pancreatic cancer biomarkers in large prospective cohorts
Validation of the Fes Tyrosine Kinase as an Inhibitor Target in Multiple Myeloma
Validation of the Pre-BCR Signaling Complex in pre-B ALL Cell Model by Two-Color Single Particle Tracking and Peptidomimetic Inhibition
Vesicular Stomatitis Virus (VSV) Replication in Malignant Cells
Viral Non-Coding RNAs and Cell Transformation
Vorinostat for GVHD prevention in unrelated donor myeloblative conditioning BMT
ZIP4 is a Novel Molecular Target in Human Pancreatic Cancer
2014
(PDQ5)Integrated Genetic and Epigenetic Prognostication for Acute Myeloid Leukemi
(PQ #4) Single cell barcoding for studies of study clonal evolution in glioblasto
(PQA1) The antipsychotic thioridazine protects against medulloblastoma (MB): volu
(PQA2) Impact of obesity on endogenous mutational hotspots
(PQA-4) Organoid Omics To Detect And Defeat Ductal Pancreatic Cancer
(PQB-2) Driver vs. passenger epigenetic events in Ewing sarcoma
(PQB2) Ontogeny of the tumor-immune interplay in a developmental malignancy
(PQB3) CD4 T cell response to BCR-ABL-positive Leukemia
(PQB-3) Driver gene-induced inflammation in pancreatic cancer development
(PQB5) Epigenetic Drivers of Hematopoietic Stem Cell Transformation
(PQB5) Reconstruction of Evolutionary Networks using Cross-Sectional Genomic Data
(PQB5)Molecular Wiring and Therapeutic Targeting of EGFR and PDGFR Signaling Netw
(PQC2) Optical Hallmarks of Aggressive Clones Within Oral Field Cancerization
(PQC5) MRI of magnetically labeled immune/stem cells for early tumor detection
(PQC5)Early Detection Pancreatic Cancer by Hyperpolarized Silicon Nanoparticles
(PQD1) lmpact of cytotoxic and targeted therapy on clonal evolution of CLL
(PQD2) Molecular Basis for the Chemosensitivity of Testicular Germ Cell Cancers
(PQD2)New Biomarkers and Pathways to Enhance Cure in Ovarian Cancers
(PQD3) Mechanisms of prolonged initial disease-free survival in glioblastoma
(PQD3)Molecular Profiles associated with Long-Term Survival in pancreas Cancer
(PQD4) MicroRNA Dysregulation in Field Effect is a Prerequisite for Tumorigenesis
(PQD5) A novel genetic strategy to predict efficacy of anti-CD20 antibodies
(PQD5) Avatar-directed Treatment for Ovarian Cancer
(PQD-5) Patient derived orthotopic xenograft models for drug response prediction
(PQD5)Biomaterials-based Adaptive Tumor Microenvironments for In Vitro Drug Scree
3D-Microtumor_GBM Xenoline Proband Modeling of Kinome-Directed Therapy
99mTc-Tilmanocept for Sentinel Lymph Node Biopsy in Cervical Cancer Surgeries
A Genetically Defined System to Identify Factors Essential for KRas Oncogenesis
A longitudinal assessment of frailty in young adult survivors of childhood cancer
A molecular mechanism whereby metformin protects against liver cancer
A Mouse Model of DNMT3A-Associated Hematologic Malignancy
A New Treatment Paradigm for ALK-Driven Cancers Exploiting Oncogene Overdose
A Novel Agent with Dual Functions to Treat Head and Neck Cancer
A novel antibody drug conjugate for metastatic renal cancer treatment
A Novel Approach to Treating Glioblastoma through Activation of the Liver X Recep
A Novel Epigenetic Circuit in Acute Leukemia
A novel functional genomic pipeline for target identification in sarcoma
A novel lineage pathway controls metabolic adaptation by metastatic lung cancers
A novel mediator of obesity associated hepatocellular carcinoma (HCC)
A Novel Multimodality Immune Based Platform in Advanced Mycosis Fungoides
A Novel Oncogenic Role for Cdc20 Implications in Adult T Cell Leukemia Treatment
A novel regimen to target both pancreatic cancer k-ras and antiapoptotic proteins
A novel role for pml bodies in leukemic transformation
A novel soluble receptor-based therapy for Kidney Cancer
A novel targeted delivery system for cancer treatment and diagnosis
A novel targeted therapy for HNSCC based on a novel activity of cetuximab
A Phase I Study of CED of Liposomal-Irinotecan using imaging in High Grade Glioma
A phase i trial combining iv fenretinide and iv safingol to target overproduction
A protein based strategy to reverse bone marrow failure resulting from radiation
A radiotherapeutic for breast cancer brain metastases
A role for notch in self renewal in embryonal rhabdomyosarcoma
A small molecule broad spectrum inhibitor of antiapoptotic genes to treat cancer
A Zebrafish Model to Study the Role of the Microbiota in the Etiology of Intestin
Actin dynamics as a therapeutic target for bcr-abl-positive acute lymphoblastic leukemia.
Active Viral Hepatitis Diagnostics to Support Prevention/Treatment of HCC
Adaptable hydrogel platform to study pancreatic cancer
Advanced Training in Urologic Oncology
ALK Rearrangements in Aggressive Thyroid Cancer
Altered microrna as a biomarker for the onset of obesity related womens cancers
Alternative End-Joining in DNA Repair and Chromosomal Translocations
An Early-Phase Clinical Trial Evaluating ABC294640 in Patients with Refractory/Re
An Epigenetic Strategy for Restoring Carboplatin Sensitivity in Ovarian Cancer
An inhibitor of multiple anti-apoptotic gene products for pancreatic cancer
An innovative in situ cell reprogramming technology for cancer treatment
Analysis of CTCs for Early Prediction of Response to Treatment in RCC
Analysis of Intratumoral Crosstalk in Clonal Populations of OvarianTumor Cells
Application of Boolean Networks to discover stem and progenitor cells
ARID5B and disparities of childhood leukemia
Aspirin and Cancer Prevention in Lynch Syndrome: From Cell to Population Data
Assay Development for NSD1 Methyltransferase Inhibitor Discovery
Assessment of hypercoagulability in cancer patients using sonorheometry
Assessment of microvessel density and tumor proximity for prognosis of cancer
Autoimmune Conditions, Genetic Variations, and Lymphoma Etiology
Autophagy as a microenvironmental regulator of tumorigenesis and resistance
Autoregister: a system for enhancing the accuracy of tumor change detection
B cell repertoire molecular platform for antibody drug discovery
Bayesian approaches for missingness and causality in cancer and behavior studies
Biomarker validation for intraductal papillary mucinous neoplasms of the pancreas
Biosensor Assay to Screen for Signaling Pathway Inhibition in Cancer
Blood-based Angiome Profiling to Direct Bevacizumab Therapy in Ovarian Cancer
Bridging the gap from discovery to survival in the interlymph consortium
Building upon a tradition of excellence. The NCTN at Indiana University
Cathepsin inhibitors for treatment of breast cancer induced bone pain
Cd4 t cell response to bcr-abl positive leukemia
Cell cycle reprogramming for therapeutic targeting of BTK in lymphoma
Cell line panel profiling for discovery of multiple myeloma therapeutics
Cellular and Biologic Origins of CLL
CendR peptide-mediated enhancement of systemic oncolytic herpes virotherapy
Central Neck Dissection in Patients with Clinical Node Negative Thyroid Cancer
CERT Imaging of Cancer
Characterization of a non-canonical role for Foxo1 in B cell lymphoma
Characterization of Drug Survival by Pancreatic Cancer Cells in vitro and in vivo
Characterization of Epigenetic Targets in Prostate Cancer
Characterization of non-competitive proteasome binding
Characterizing the genomic architecture and molecular mechanisms driving the form
Chemical Modulation of Chromatin Signaling in Lymphoid Malignancies
Chemical optimization of a novel class of usp7 inhibitor for cancer treatment
Chemically Programmed Bispecific Antibodies for Cancer Therapy
Chemically programmed bispecific antibodies for cancer therapy
Chemofilter: a novel catheter device to enable high-dose chemotherapy treatment
Childrens Oncology Group Statistics and Data Center
Chronic stress in the absence of blm induces metabolic alterations
Clinical development of cancer-specific MRS biomarkers in malignant gliomas
Cll mutation detection and monitoring from blood using ac electrokinetics
Clustered semi-competing risks analysis in quality of end-of-life care studies
Cog nctn network group operations center
COG NCTN Solid Malignancy Integrated Translational Science Center
Collaborative Human Tissue Network (CHTN)
Comprehensive Approach to Improve Medicine Adherence in Pediatric Leukmia
Conferring in vivo metabolic resistance to a highly selective anti-AML agent
Contractor: mayo clinic; dunns: 006471700; pilot study of egfr inhibition with erlotinib in cirrhosis to inhibit firbrogenesis and prevent hepatocellular carcinoma hhsn261201200042i; task order hhsn26
Control of the apoptosome in epithelial ovarian cancer to enhance chemotherapy
Cooperating Pathways in Gliomagenesis
Correcting aberrant splicing of the human cd22 gene
Cytotoxicity of MLN4924 in Acute Myeloid Leukemia
Deciphering the pathogenesis of pediatric high-grade gliomas
Defining microRNA Signatures for Early Detection in BRCA-Mutated Ovarian Cancer
Defining novel drivers and predictive signatures of metastasis in osteosarcoma th
Defining the Role and Mechanism of Pak1 in Supporting Pancreatic Cancer
Defining the Tn-glycoproteome of in situ colorectal tumors and mechanisms of Tn e
Descriptionpatterns of care/quality of care study: diagnosis year 2013 (seer)period of performance: 08/15/2014-08/14/2015line item #: 1
Detection of cox-2-expressing bladder cancer by fluorocoxib a
Determining the kinetics and mechanism of pancreatic tumor regression following genetic deletion of PI3K p110a
Determining the role of CUX1 in myeloid neoplasia
Developing an Anti-sialyl-Lewisa Diabody for ImmunoPET Imaging of Pancreas Cancer
Developing CRM1 inhibitors in AML
Developing Novel STAT5 Protein Inhibitors for treatment of leukemias
Development and Application of Selective Covalent Cdk7 Inhibitors
Development of a coiled-coil therapeutic for non-hodgkin’s lymphoma
Development of a Small Molecule Inhibitor for KSHV LANA
Development of Advanced C-arm Cone-Beam CT for the Treatment of Liver Cancer
Development of Gli1-Selective Therapeutics for Hedgehog Pathway-Dependent Cancers
Development of Integrated Analysis Methods and Applications to TCGA data
Development of integrated analysis methods and applications to tcga data
Development of transporter targeted platinum drugs for pediatric tumor
Diagnostic assays for ovca recurrence using paraneoplastic antigens and epitopes
Directional Motility and ERM Scaffolding in Pathfinder Pancreatic Carcinoma Cells
Discoidin Domain Receptors: Novel Players in Pancreatitis and Pancreatic Preneoplasia
Discovering genomic rearrangements under selection in serious ovarian cancer
Discovery of Homologous Recombination DNA Repair Deficiency in Lung Tumor
Discovery of Risk Loci and Genomics of Pancreatic Cancer through Exome Sequencing
Disrupting Brain Metastogenesis in Breast Cancer
Dissecting the genetics of follicular lymphoma to find new therapies
Dissecting the role of stat3 and targeting ovarian cancer
Dissecting the roles of TSC1 and TSC2 at the centrosome
Distribution, regulation and function of a novel lysine ptm in metabolic disease
DNA-PKCS Phosphorylation in DNA Repair and Chromosomal Translocations
Drosophila models of Ret fusions in Papillary Thyroid Carcinoma
Dual targeted nanoparticle therapy for glioblastoma multiforme
Dynamical Models of Cetuximab Resistance in HNSCC Based on Serial Genomics Data
Early detection of pancreatic cancer in diabetics
Ecog-acrin integrated leukemia translational research center
Effects of uv irradiation on dna structure-induced genetic instability
Elucidate the role of miR-141 in brain metastasis from breast cancer
Elucidating and targeting epigenetic oncogenic networks in pancreatic cancer
Elucidating the role and regulation of epithelial plasticity in metastasis
Embryonal Brain Tumor Networks
Enable early and sensitive in vivo detection of liver metastasis by protein-based
Endothelial cell activation regulates aml growth and relapse
Engineering a supramolecular platinum nanoparticle for pediatric cancer
Engineering alpha fetoprotein and glypican-3 to develop hepatoma (HCC) vaccines
Engineering organelle function to rewire cancer cell metabolism
Enhancing Glioma-Specific Immunity
Enhancing NK Cell Activity by Dietary Diphyllin Lignans for Cancer Prevention
Enhancing oncolytic virus function with type iii interferon
Epigenetic modulation of lung cancer metastasis by a novel long intergenic RNA
Epigenetic priming in pancreatic cancer chemotherapy
Epigenetic regulation of pancreatic cancer
Epigenetic regulation of T-cell dysfunction in chronic lymphocytic leukemia
Epigenetics and Risk Factors for Breast and Ovarian Cancer in High Risk Women
Epo increases macrophage suppression
ERK inhibitor resistance and ERK isoform-dependent growth in pancreatic cancer
Establish RPN 13-Proteasome Association as a Novel Anticancer Target
Evaluating Notch Signaling as a Therapeutic Target in Ovarian Cancer
Evaluation of impact of anti-VEGF drugs on concomitant chemotherapy in GBM
EVALUATION OF POSITRON EMISSION TOMOGRAPHY-MAGNETIC RESONANCE IMAGING (PET-MRI)
Ex vivo purging strategy for treatment of multiple myeloma
Exercise and quality diet after leukemia
Exosomal MicroRNA as a Driver of Immune Evasion in AML
Exploiting Metabloic Defects in Tumors with Mutant IDH1 and IDH2
Exploring a new therapeutic approach through targeting epigenetic enzymes in all
Exploring the role of Mediator in oncogenic transcription
Expression system and process development for mis scale up
F10: a novel therapeutic to treat refractory or relapsed aml
Failed tubulin inhibitor reformulated as localized adjuvant therapy for head and neck cancerpop: 09/12/2014-06/11/2015
Fatty acid transporters in cholangiocarcinoma pathogenesis
Fingerprinting Invasive Membrane Protrusions to Discover Metastatic Signatures
Fluorescence lifetime imaging/spectroscopy system for robotic cancer surgery guid
Fluorescence lifetime technique for detection of radiation necrosis vs gliom
FoxM1 in liver cancer.
Frostbite – a unique catheter for endoscopic cryoablation
Fullerene-based radioprotectors for use during brain radiotherapy, period of performance 09/15/2014 – 05/15/2015
Function of the PR domain of the MDSI-EVI1 in MLL fusion protein leukemogenesis
Function on Non-Coding RNA, MALAT1, in B-cell development and Lymphoma
Functional analysis of BRCA1 in DNA damage response and tumor suppression
Functional Analysis of LncRNAs in Epithelial Ovarian Cancer
Functional and biologic significance of deacetylase3 inhibition in myeloma
Functional Significance of CD133 in Pancreatic Cancer
Functional significance of pre-leukemic hsc in human acute myeloid leukemia
Genetic Dissection of Acute Myeloid Leukemia.
Genetic Modifiers for Cancer Stem Cells in Secondary MDS/AML
Genetic Testing For Men From Hereditary Cancer Families
Genomic Instability from Loss of XPG, a BRCA1/2 Partner: Role in Ovarian Cancer?
Genomic instability mediated via differential DNA repair mechanisms in B cells
Genomic profiling and development of murine models of transformation of MPNs
Germline Susceptibility in Double Primary Cancers via Nexy-Generation Sequencing
Global Assessment of Myeloma Response to Chemotherapy
Glycocalyx and ncor2-notch-mediated stemness in glioblastoma aggressiveness
GPCR Signaling in SCCHN: Integration with EGFR
GPCRs: novel targets in cancer-associated fibroblasts
GSK3 inhibition as an adjuvant therapy for Burkitts lymphoma
H3K9 Methylation and Pancreatic Cancer Chemoresistance
Harnessing the Multipotency of Cancer Stem Cells for Differentiation Therapy
HDAC8 Mediated Regulation of Acute Myeloid Leukemia Pathogenesis and Maintenance
Healthy Kids after Cancer: A Physical Activity and Nutrition Intervention
Hedgehog Acyltransferase as a target in cancer
Hereditary cancer predisposition syndromes and uveal melanoma
Hhsn2612012000131/hhsn26100010base contract title: preclinical efficacy and intermediate endpoint biomarkers. Task order title: preclinical studies to evaluate the combination of metformin and as
Hhsn2612012000151/hhsn2610006base contract title: preclinical efficacy and intermediate biomarkers. Task order title: modulation of mirna expression in blood or other biological fluids compared wi
Hhsn2612012000201/hhsn26100006 title: preclinical in vitro and in vivo screening assays for cancer preventative reagent development, project: targeting cck2r for pancreatic cancer prevention
High dose radiation therapy to direct immune responses to pancreatic cancer
High Resolution Helicobacter SNP Typing to Identify Carcinogenic cagPAI Variants
Highly Specific and Efficient Vectors for Targeting Pancreatic Cancer
High-resolution analysis of chromatin regulation by the Max network
Hormonal effects on fallopian tube and ovary inclusion cysts, and ovarian cancer
Human-Enzyme Mediated, Systemic Depletion of Cystine for Cancer Treatment.
Identify OTX2-interacting proteins repressing differentiation in medulloblastoma
Identifying Biomarkers of Cisplatin Resistance Mechanisms in Ovarian Cancer
Identifying new drug targets to block K-Ras/Raf in pancreatic cancer.
Identifying signaling and anti-apoptotic dependencies in acute myeloid leukemia
Identifying STAT3 Co-dependencies in Cancer
Igf maternal folic acid supplementation and leukemia risk in children: a pooling of prospective data in the international childhood cancer cohort consortium (i4c)
Igf::ot::igf – ind enabling development of nanogmp: targeted
Igf::ot::igf sbir phase i topic 331: biopsy guidance with coherent raman spectroscopy
Imaginab
Imaging Guided Surgery using Fluorescently Labeled Cetuximab
Imaging IDH1 Mutations in Glioma and Other Malignancies
Immune-based brain cancer diagnostic for rapid, accurate disease classification
Immunity to MHC-restricted phosphopeptides in healthy donors and cancer patients
Impact of low IL-10 levels at birth and leukemia risk
Impact of malaria on shaping immunity to EBV in the etiology of Burkitt lymphoma
Impact of primary tumor development stage on prognosis and outcome in B-ALL
Impact of Short Inverted Repeats on Genetic Instability at Mutation Hotspots
Improved Response Assessment in Anti-Angiogenic Treatment of Glioblastoma
Improving CPT-11 Efficacy Using Structural and Chemical Biology
Improving extent of glioblastoma resection by combining volumetric MRSI and 5-ALA
Improving Self-management in Head and Neck Cancer
In Vivo Study of of Chemokine Antagonists for Cancer
Individualized Peptide Monitoring for Plasma Cell Dyscrasias by Proteomics
Inflammation, autoimmunity and ovarian cancer
Inflammatory basis of depression in ovarian cancer
Influence of germ line genetic variation on myeloma progression and survival
Inhibiting STAT1 as a novel graft-versus-host/graft-versus-leukemia therapy
Inhibition of PGE2 for mobilization of autologous peripheral blood stem cells
Instructive cues in glioblastoma hierarchies
Intact protien as a cancer fuel source
Integrated Microfluidic Exosome Profiling for Early Detection of Cancer
Integrated models for metastatic phenotype and outcome prediction in osteosarcoma
Integrated Translational Genoproteomics Center at Washington University
Integrating mass cytometric and transcriptomic profiles of solid tumors
Integration of glycolysis with the epithelial-mesenchymal transition
Integrative Modeling of Gene Expression into GWAS of Glioma
Integrin AVB3 Targeted Nanoparticles as a Novel Therapy of Bone Metastases
Interactive Omics: Black raspberry metabolites and the oral microbiome in smokers
Interferon Activated Necroptosis as a New Therapeutic Avenue for Kidney Cancer
Intervention of Ras-ERK-activated cancers
Intervention of ras-erk-activated cancers
Intraoperative confocal microscopy for quantitative delineation of low-grade glio
Intraperitoneal Delivery of Targeted Nanoparticles for Metastatic Ovarian Cancer
Intravenous Administration of Vesicular Stomatitis Vectors
Investigating and Targeting TAMs in the Glioma Microenvironment
Investigating Branched Chain Amino Acid Metabolism in Pancreatic Cancer
Investigating LGR5/Wnt signaling in Ewing sarcoma pathogenesis
Investigating Resistance to FLT3 Inhibitors in AML
Investigating the association between the somatic and inherited genetics of pheoc
Investigating the cause of racial/ethnic disparity in hepatocellular cancer risk
Investigating the function of mtbp in lymphoma
Investigating the roles of lncRNAs in cancer and development
Investigating Wnt and Lgr5 signaling as regulators of lung cancer heterogeneity
Investigation of therapeutic modulators of apoptotic priming in pancreatic cancer
Investigation of tumor suppressive miR-148a in IDH mutant gliomas
Investigations of Cryab activity in gliomagenesis
IRE1/XBP1s signaling: a novel essential regulator for bone marrow microenvironmen
Iron addiction and the biology of ovarian cancer
Itraconazole Analogues to Treat Medulloblastoma
ITSC for Leukemia: Novel Molecular Strategies for NCTN: Individualized Therapie
Kaposis Sarcoma-associated Herpesvirus Mimics of Cellular microRNAs
Kir-favorable haploidentical transplantation in children
KSHV alteration of cellular metabolism
KSHV interactions with host inflammasome components
Large scale synthesis and biodistribution of expansile nanoparticles
Large-Scale Characterization of Anti-Cancer Antibody Responses in Lung Adenocarci
Pathogenesis of Malignant Mesothelioma by the Human Polycomb Complex BAP1-ASXL
Pathogenetic and prognostic studies for improved therapy of Merkel cell carcinoma
Pathogenetic Mechanism and Clinical Targeting of CSF3R-Driven Cancer
Pathogenic Mechanisms of CSF3R Mutations in Leukemia
Pathophysiology of Chemotherapy-Induced Cognitive Deficits in Juvenile Rats
Patterns of care/quality of care study: diagnosis year 2013 (seer)period of performance: 08/15/2014-08/14/2015
Patterns of care/quality of care study: diagnosis year 2013 (seer)period of performance: 08/15/2014-08/14/2015line item #: 1
Patterns of care/quality of care study: diagnosis year 2013 seer) hhsn261201300017i – university of utah; pop 08/15/2014 – 08/14/2015 to# hhsn261200004
Patterns of care/quality of care study: diagnosis year 2013seer) hhsn261201300015i – emory university pop 08/15/2014 -08/14/2015, to# hhns261200005
Patterns of care/quality of care: diagnosis year 2013 (seer)pop 08/15/2014 – 08/14/2015line item#: 1
PD2/Paf1 and pancreatic cancer stem cells
Peptide reporters for estimation of bcr-abl kinase activity in all patient cells
Peptide-mediated delivery of siRNA for treatment of ovarian cancer
Perinatal hormonal biomarkers and risk of testicular germ cell tumors
Perinatal immune development and risk of childhood acute lymphoblastic leukemia
Perioperative Stromal Depletion Strategies in Pancreatic Ductal Adenocarcinoma
Persistent SIX2 expression as a first hit mechanism in Wilms tumorigenesis
PET Imaging-guided Personalized Therapy in Pancreatic Cancer
PET/MR study of Metastatic Lymph Nodes in Head and Neck Cancer
Phase I Vaccine Study using Brain Tumor Initiating Cells in WHO Grade II Gliomas
Phenotypic plasticity associated with inhibition of hsp90
Phosphoinositol-3-Kinase Signaling and PIK3CA: Critical Mitogenic Drivers in Head
Phosphorylated Form of Activated IKKbeta and Pancreatic Cancer
PI3K Pathway Inhibition for Philadelphia-Like Acute Lymphoblastic Leukemia
Plasma and serum biomarkers for Hodgkin lymphoma
Pluripotent stem cells as a novel model to test hereditary cancer variants
Posterior cerebellar resection and pain processing in the pediatric brain
Potential therapeutic implications of targeting miR-150 in acute myeloid leukemia
PQD2 Rational Combination of Standard Agents and Immunotherapy to Treat Myeloma
Preclinical evaluation of a targeted Bmi1 inhibitor in pancreatic cancer
Preclinical Validation of U1 Adaptors for Suppression of KRAS in Pancreatic Cancer
Predicting hcc through glycomics
Prediction of Treatment-Related Mortality and Therapeutic Resistance in AML
Predictive MRI metrics for tumor aggressiveness in micropapillary thyroid cancer
Pre-Leukemic Hematopoietic Stem Cells and Clonal Evolution in Human AML
Prevention of bone loss after pediatric hematopoietic cell transplantation
Professional development and late career transitions in pediatric hematology/onco
Prognostic Metabolic Signatures of Cancers Through Mass Spectrometry Imaging
Prognostic potential of low-level mutations in meylodysplastic syndrome
Prohibitin 1 in liver injury and cancer
Prospective Study of Human Oral Microbiome and Pancreatic Cancer Risk
Protein-coding and non-coding RNA biomarkers for early detection of CLL
Puerto Rico NCI Community Oncology Research Program Minority/Underserved
Quantitative (Perfusion and Diffusion) MRI Biomarkers to Measure Glioma Response
Quantitative Analysis of GBM Invasion Mechanisms with New Imaging Protocol
Quantitative MRI models of HN Cancers for Physiological Adaption of RT
Quantitative MRSI for the prediction of response to chemoradiation therapy in GBM
Radiation and Receptor Targeted RadioTheranostic Nanoparticles for Glioblastoma
Radiolabeled Trastuzumab to Improve Diagnosis and Staging of HER2+ Gastric Cancer
Reactivation of p53 and apoptosis in patient derived aml cells with cytoplasmic s
Reactive Oxygen Species-Induced CXCL8 in Ovarian Cancer
Refining ovarian cancer subtype classifiers to incorporate biologic features
Regulation of cell migration by septin 2 in renal cancer
Regulation of Lung Cancer Metastasis by ZEB1
Regulation of redd1 and caspase-2 by fasn inhibition in ovarian cancer
Regulation of transcription and tumor suppression by MTG family members
Replicating tumor ecm in microchannels for 3d phenotypic hts assays
REPROGRAMMING THE METASTATIC MICROENVIRONMENT OF PANCREATIC CANCER THROUGH CSF1R
Research career advancement: Role of the SIRT1 deacetylase in maintenance of FLT3
Risk of hematologic cancers from repeated low-dose diagnostic radiation
Role of acetyl-CoA in linking cancer cell metabolism and epigenetics
Role of Age in Liver Cancer
Role of Asxl1 in normal hematopoiesis and pathogenesis of myeloid malignancies
Role of autophagy in normal and transformed hematopoietic stem cells
Role of beta-catenin in apoptosis resistance of hepatocellular carcinoma
Role of epigenetic regulators in pancreatic cancer
Role of ErbB receptor signaling in regulating normal and leukemic stem cell fate
Role of FOG2/GATA3 complex in lung cancer metastasis
Role of IKAROS in the Biology and Therapy of High-Risk Precursor B-Cell Leukemia
Role of inflammation in cancer progression
Role of MEF2B mutations in lymphomagenesis
Role of microRNAs in the regulation of CML stem cell self renewal and survival
Role of MLL1 and MLL1 leukemogenic fusions in maintaining transcriptional memory
Role of multiple myeloma cancer stem cells in clinical disease
Role of p21 activated kinase in Leukemogenesis
Role of Piceatannol in Cancer Cachexia
Role of tumor-associated endothelial cells in chaperoning tumor cells
Sbir phase ii topic “scalable automated brain tumor segmentationâ€
Screening for inhibitors of the CBX chromodomain
Second generation mti-101 analogs using a novel peptoid-peptide hybrid beta-hairp
Selective transduction of radioprotector protein, Tousled, for treatment of cance
Sensitize leukemia cells to differentiation by inhibiting necroptosis signal
Sequence-based pathogen discovery in post-stem cell transplantation syndromes
Shanghai Womens Health Study
SHCC MU NCORP
Signal Integration of Transcriptional Pathways in Gliomagenesis
Signaling and Targeting of 6-Phosphogluconate Dehydrogenase in Human Cancers
Sirt2 Directs Kras IR Cell Resistance and Tumorigenesis
Small Molecule Activators of Pro-apoptotic BAX for Cancer Therapy
Smart targeting nano-doxorubicin against breast cancer
Smo inhibitor resistance in shh-subtype medulloblastoma: mechanisms and treatment
Sox9 signaling in lung adenocarcinoma
Specificity of the Ubiquitin System in Lymphoid Malignancies
Specificity of the ubiquitin system in lymphoid malignancies
Stanford University NCTN- Network Lead Academic Site
Stellate cells and their progenitor precursors in pancreas cancer progression
Stem Cell Gene Therapy Following R-EPOCH for Non-Hodgkin Lymphoma in AIDS Patient
Stem Cell Phenotype, GLUT3 expression, and Metabolic Stress Resistance in Gliobla
Steroid Hormones Regulate Ovarian Cancer Progression and Metastasis
